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Abstract 
Clinical studies have shown that up to 73.9% of the 1.04 million US lower limb amputees 
report skin problems such as sweating, irritation, and sores associated with their conventional 
prosthesis. An alternative option redirects ambulatory forces back to the skeleton using an 
implant that permanently protrudes through the skin (transcutaneous) to enable direct bone 
anchorage (osseointegration) of a prosthesis. Transcutaneous osseointegrated prostheses show 
a marked improvement in amputee acceptance over conventional prostheses. Advantages 
include limited tissue breakdown, a non-restricted range of motion, and enhanced 
functionality. However this prosthetic option has not been clinically implemented in the United 
States because of infection concerns and an incomplete understanding of transcutaneous 
wound healing. Being a potential state-of-the-art altering surgical option for trauma-induced 
amputees, transcutaneous osseointegration will require preliminary animal studies. 
To evaluate the efficacy of the transcutaneous osseointegrated option, a physiologically- 
similar, axially-loaded, weight bearing animal model was developed. Two pigs were fit with 
transcutaneous osseointegrated prostheses in a single-stage amputation and implantation 
surgical procedure. Clinical, microbiological, and histological data were examined to assess 
wound healing and infection at the skin-bone-implant interface. The animals achieved 70% and 
67% pre-operative weight-bearing. Bacterial cultures indicated a likely deep tissue infection in 
one of the two animals. The transcutaneous wounds were in the proliferative phase of wound 
healing by the end of the 35 and 56 day studies. The epithelial skin layer was migrating towards 
the implant in one animal.  
Results obtained from the animal model will be used to implement future topographical 
and material changes at the transcutaneous site. The porcine model should become the 
standard for implementing and testing future iterations of weight-bearing transcutaneous 
osseointegrated prosthetic devices.  
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1.1 Overview 
1.1.1 By the Numbers 
It is estimated that 1.6 million people in the USA, or one out of every 195 citizens, have 
had an amputation resulting in limb loss [1].  The lower extremities are at greater risk, 
constituting 1.04 million (65%) of all amputees. Vascular disease is the cause of 54% of lower 
limb amputations, trauma 45%, and cancer 1%. US amputations occur most often in an aging 
population as 42% of amputees are 65 years or older. Sixty-five percent (65%) of amputees are 
men and 42% of amputees are nonwhite. Of all lower limb amputations, 60% are categorized as 
major (i.e., excluding only toes). Of all amputations at the level of the knee, above-knee (AK) 
accounted for 48.3% and below-knee (BK) constituted 51.7%. There is an increasing trend in the 
number of amputations. By the year 2050, there will be a projected 3.6 million American 
amputees [2]. Sufficient data is not available to estimate the number of worldwide amputees.  
The United States Armed Forces compiles detailed injury statistics for service members. 
During the years 2000 to 2011, there were 6,144 amputations among soldiers engaged in 
ground combat operations while on deployment or in other settings [3]. Of these, 2,037 (33%) 
were major limb amputations. As of December 2012, 1,715 service members had an 
amputation during Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF). 
Eighty-seven percent (87%) of these amputations were major limb [4]. 
 
1.1.2 Project Motivation 
Clinical studies have shown that up to 73.9% of the 1.04 million US lower limb amputees 
report skin problems such as sweating, irritation, and sores associated with their conventional 
prosthesis. Transcutaneous osseointegration prosthetic devices, which permanently protrude 
through the skin (transcutaneous) to enable direct bone anchorage (osseointegration) of a 
prosthetic limb, offer an alternative option for connection of a prosthetic to the body. 
Transcutaneous osseointegration prosthesis, which will be further discussed in the following 
thesis chapters, have yet to receive FDA approval for clinical use in the United States. Although 
over 250 of these procedures have been performed on humans, primarily in Europe, the US 
health care system is hesitant to implement the amputation and implantation technique largely 
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because of concerns about potential bacterial complications around the implant and 
mechanical failure of the bone/implant interface (i.e., fixation) [2]. Before transcutaneous 
osseointegration techniques are introduced in the US, these complications will need to be 
sufficiently resolved via computational models, animal studies, and human clinical trials. This 
pilot study is the initial investigation into the establishment of an appropriate in vivo large 
animal model for transcutaneous osseointegrated prostheses.  
1.2 Conventional Prosthetic Suspension 
1.2.1 Introduction to Conventional Prosthetic Suspension 
The earliest of rehabilitative lower limb prostheses date back to the Greek and Roman 
civilizations of 300 BC [5]. These were weight-bearing prosthetic legs made of wood and 
secured to the body with leather straps. While advancements in material science and robotics 
have made the lower limb prosthesis lighter, stronger and more functional, the prosthetic limb 
attachment has remained largely unchanged for the last 2,000 years. Straps, belts, sleeves, or 
suction remain the primary attachment options for today’s amputees [6].  
1.2.2 Problems with Conventional Suspension 
Modern lower limb amputation techniques have progressed to improve patient 
satisfaction. They attempt to achieve the following: a skin incision away from a potential rub 
site of a prosthetic limb, smoothed bone edges, remaining muscle shaped to provide sufficient 
padding around the residual bone, and nerves cut proximally to minimize pain. Even with these 
adaptations, the soft tissues of the residual stump still encounter all of the force and wear that 
is normally associated with ambulation. It has been shown that repeated loading of soft tissue 
may hinder the local blood supply and lymphatic system [7]. High-frequency and long-term use 
of a socket prosthesis can lead to local cell necrosis, tissue breakdown and eventual skin sores 
(Figure 1.1). Beyond skin problems, some amputees are left with a residual limb too short to 
enable adequate mechanical fixation with conventional suspension [8]. This is often the case in 
trauma-induced amputations. 
Table 1.1 at the end of this section summarizes the reports of skin problems associated 
with conventional prosthetic suspension. In a study of 261 prosthetic-wearing amputees, 30 
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patients (11%) encountered skin problems requiring treatment from a health center [9]. The 
most commonly diagnosed skin problems were pressure sores, irritant contact dermatitis, 
negative pressure hyperemia, intertrigo, and xerosis. A survey of ninety-seven amputees with 
unilateral trans-femoral amputations reported common troubles associated with the 
conventional prosthetic suspension [10]. One quarter of those amputees surveyed considered 
their quality of life to be poor to extremely poor because of problems associated with their 
prosthesis. Problems included sweating (72%), skin irritation (62%), limited mobility (61%), and 
stump pain (51%). In a questionnaire-based study of 210 amputees, 71 (34%) reported a skin 
problem. Problems included lesions and contact dermatitis [11]. A clinical study of 124 
amputees estimated a 36% prevalence of skin problems of the stump due to the prosthesis 
[12]. The most commonly reported problems were pressure ulcers (39%) and infection (25%). 
Of those participants with prosthesis-induced skin problems, 50% reported a reduction in 
prosthesis use and 54% reported a reduction in walking distance without taking a break.  In a 
six-year retrospective chart review of 828 lower-limb amputees, 337 (41%) had at least one skin 
problem [13]. Commonly reported skin problems were ulcers (27%), irritation (18%), inclusion 
cysts (15%) and callus (11%). Amputation level, type of employment, type of walking aid, and 
peripheral vascular disease were all statistically correlated with the incidence of a skin problem. 
In a survey of 581 veterans and service members of Vietnam and OIF/OEF, 58% reported that 
they were bothered by skin problems associated with their prosthesis [14]. Commonly reported 
problems included pain, sweating, skin irritation, and socket fit. A clinical study of 142 
amputees reported skin problems in 105 (73.9%) of them [15]. Of those patients reporting skin 
problems, contact dermatitis was the leading cause (54.3%).  
Differences in inclusion criteria between the studies led to a considerable range (11%-
73.9%) of patients reporting “skin problems” (Table 1.1). Nevertheless, the clinical studies 
demonstrate that the conventional prosthetic suspension leaves amputees with pain, infection, 
and an uneven pressure distribution on the residual stump. These skin problems culminate in 
limited mobility and demonstrate the clinical need for improved methods of prosthetic 
attachment.  
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Figure 1.1: Problems with conventional suspension. a) An amputee with pressure sores, b) 
Contact dermatitis on the proximal edge of the prosthesis’ contact surface. Images reproduced 
from Highsmith et al. (2007) [9]. 
 
Table 1.1: Skin problems associated with conventional prosthetic suspension 
Type of Study (Publication Year) Skin Problems Common Problems 
Clinical assessment (Highsmith et al., 2007) 30/261 (11%) Pressure sores, irritant contact 
dermatitis, negative pressure 
hyperemia, intertrigo, xerosis 
Questionnaire-based (Hagberg et al., 2001) 24/97 (25%) Sweating, skin irritation, limited 
mobility, stump pain 
Questionnaire-based (Lyon et al., 2000) 71/210 (34%) Lesions, contact dermatitis 
Questionnaire-based and clinical assessment 
(Meulenbelt et al., 2011) 
45/124 (36%) Pressure ulcers, infection 
Retrospective chart review (Dudek et al., 2005) 337/828 (41%) Ulcers, irritation, inclusion cysts, 
callus 
Veteran survey (Berke et al., 2010) 337/581 (58%) Pain, sweating, skin irritation, 
socket fit 
Clinical assessment (Koc et al., 2008) 105/142 (73.9%) Contact dermatitis 
 
 
 
a b 
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1.3 Transcutaneous Osseointegration (OI) Method 
1.3.1 Introduction to Transcutaneous OI  
An alternative option to socket-stump artificial 
limb attachment, known as transcutaneous 
osseointegration, redirects the forces of loading entirely 
back to the skeleton, bypassing the soft tissue, and thus 
circumventing many of the soft tissue problems 
associated with conventional prosthetic suspension. This 
technique uses a transcutaneous prosthesis to enable 
direct bone anchorage of an implant (Figure 1.2).  
“Osseointegration” was a term coined in the 
1950’s by Per-Ingvar Branemark to describe permanent 
fixation and integration of titanium and bone. Initially, 
Branemark’s work focused on the circulation of bone marrow using a channeled titanium 
implant within the ear chamber of a rabbit [16]. After some time, Branemark was unable to 
remove the titanium screws from the bone because the interface had become completely 
fused. Bone and vessels had grown into the titanium chamber and could not be separated 
without fracture. Inadvertently, Branemark showed that titanium has properties capable of 
permanent fixation with bone. Branemark originally defined osseointegration as a direct 
structural and functional connection between ordered living bone and the surface of a load-
carrying implant [17]. The current definition defines osseointegration as a non-progressive 
relative movement between the directly contacted implant and bone while subjecting the 
interface to all normal conditions of loading [16]. 
Osseointegration was first established as a reliable and effective treatment in the field 
of dental reconstruction. Since 1965, it has been used clinically to replace single teeth, bridges, 
and overdentures supported by implants in more than 2 million patients [18]. A retrospective 
dental study reported a 90% implant survival rate at 15 years post-implantation [19]. Research 
momentum has more recently shifted to studies focused on facial prosthesis, bone-anchored 
Figure 1.2: Transcutaneous OI 
schematic 
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hearing aids, finger joint prosthesis, and most notably for this thesis, lower limb amputations 
[16].  
Lower limb transcutaneous OI procedures currently require two surgeries and an 
extensive rehabilitation treatment. At the first surgery (S1), a titanium insert is implanted into 
the medullary cavity and the site closed for a period of unloaded healing. This healing period 
ranges from six weeks to six months depending on the healthcare provider’s recommendation. 
The second surgery (S2) reopens the residual limb to expose the distal end of the insert. A 
transcutaneous abutment is then permanently fixated into the insert with its distal end 
protruding through the skin (Figure 1.3a). The Osseointegrated Prostheses for the 
Rehabilitation of Amputees (OPRA) protocol details an additional six month rehabilitation 
period with incrementally increasing loads and weight bearing activity [20]. Introduced in 1999, 
the OPRA protocol has limited the frequency of failure by standardizing the treatment [21]. The 
external prosthetic attachment is then connected to the abutment allowing for patient 
ambulation (Figure 1.3b). This transcutaneous OI option has shown promise in enabling 
amputees a statistically significant better Health Related Quality of Life [22].  
 
 
Figure 1.3: Human transcutaneous OI patients. a) Patient with transcutaneous OI endo-
prosthesis implanted into femur, b) Patient securing exo-prosthesis to the endo-prosthesis. 
Images reproduced from Hagberg et al. (2005) [23]. 
 
a b 
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1.3.2 Advantages of Transcutaneous OI  
Advantages of transcutaneous OI prosthetics include less pain [18], limited tissue 
breakdown [18], easier donning and doffing [18], proper prosthetic fit [18], non-restricted 
range of motion [18, 23], and enhanced control of the residual limb [18]. As an extension of the 
bony skeleton, OI prosthetic limbs also have amputees reporting improved sensations of 
proprioception, i.e., the sensory feedback transmitted through the prosthesis [18, 24]. In a 
retrospective study, the 100 patients treated at Sahlgrenska University Hospital in Sweden 
reported improved prosthetic use and mobility scores with decreased problem scores after 
switching from conventional to OI prosthetics [21]. Twelve amputees from this group 
participated in a temporal gait study to demonstrate the functional advantages of the 
prosthesis. The transcutaneous OI amputees performed cadence, gait cycle duration, stance 
and swing phases that were 2% quicker, 3% shorter, 6% shorter, and 1% longer than socket 
amputees and 11% slower, 9% longer, 6% longer, and 13% longer than able-bodied 
participants, respectively [25]. These results demonstrate the functional improvement over 
conventional suspension. 
 
1.3.3 Problems with Transcutaneous OI 
Attachment of lower limb prostheses by means of transcutaneous OI implants offers the 
potential for vast improvements over conventional lower limb socket-secured prostheses. 
Complicating the comparison, however, is the nature of the transcutaneous implant. 
Marsupialization, permigration, avulsion, and most notably infection are all modes of failure 
which must be addressed in the presence of a foreign, metal implant permanently breeching 
the skin barrier [26]. Marsupialization, or epidermal downgrowth, occurs when the epidermis 
grows internally along the percutaneous post creating a sinus tract surrounding the implant. 
Permigration refers to marsupialization with a porous percutaneous post. Over time, the 
implant extrudes as the post fills with cell debris. Avulsion refers to a tearing away of the 
implant from the soft tissue due to externally applied mechanical forces. Infection is the most 
concerning mode of failure for clinical implications. The permanence of the surgical insult 
created in the skin by a transcutaneous implant undermines the protection function of the 
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natural human skin barrier. In healthy skin, the outermost layer of the skin’s epidermis, known 
as the stratum corneum, functions as the body’s first barrier to infection. With this skin layer 
compromised, the body is susceptible to bacterial and viral infiltration, thus dramatically 
increasing the rates of deep tissue infection [27]. Infected tissue around the implant can 
ultimately precipitate implant removal; thus eradicating the advantages of transcutaneous, OI 
implants [27-29]. 
Mechanical failure of fixation and subsequent loosening of the OI implant, previously 
considered problematic, have been addressed through numerous dental and orthopedic studies 
[19, 30, 31]. Threaded and porous in-growth implant surfaces have both been successfully used 
as the method of fixation to the bone. A radiostereometric analysis (RSA) of 51 transfemoral 
patients indicated a stable fixation in all threaded implants [31]. There do remain some 
unanswered questions such as how the bone surrounding the implant remodels. Xu et al. used 
clinical x-rays and finite element (FE) modeling to correlate bone remodeling in the femur to 
the stress/strain distribution induced by ambulation [32]. Clinical x-rays of 11 transcutaneous OI 
patients showed bone absorption at the distal end of the implant and bone formation at the 
proximal end. The authors concluded that this type of bone remodeling could not be described 
by only the stress/strain adaptive bone remodeling theory or the fluid flow base stress gradient 
theory. Instead, the observed bone remodeling was a function of both overall stress/strain level 
and stress gradient.   
Frossard et al. analyzed patient gait to determine that the maximum load applied to the 
implant along its long axis constitutes 120% of the amputee’s body weight [33].  High subject to 
subject variability of applied loading indicated that the mechanical design of the implant should 
be customized per amputee [34]. The personalized nature of an implant could lead to increased 
patient costs for amputees that choose a transcutaneous OI prosthetic.  
 
1.3.4 Human Transcutaneous OI Devices 
Three distinct transcutaneous OI implant designs have been used in European human 
clinical applications: 1) OPRA system (Integrum AB, Göteborg, Sweden), 2) Integral Leg 
Endo/Exo Prosthesis (ESKA Implants AG, Lübeck, Germany), 3) ITAP system (Royal National 
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Orthopaedic Hospital, Stanmore, Middlesex, UK). All three of the implant systems attempt to 
use a soft tissue seal around the implant as the primary barrier to bacterial infection.  
Developed in the 1990’s, the OPRA system is a two part implant consisting of a threaded 
titanium, bone-anchoring fixture and a skin penetrating abutment (Figure 1.4a). The associated 
surgical technique removes excess soft tissue from the residual limb in an attempt to stabilize 
the healing wound. Reducing relative motion near the implant is thought to improve the skin 
seal at the bone [35].  
Developed in 1999, the Integral Leg Prosthesis (ILP) Endo/Exo system is a three piece 
implant consisting of a cobalt-chromium-molybdenum stem coated with a porous Spongiosa 
Metal II, a stability piece, and a transcutaneous adapter (Figure 1.4b).  The associated surgical 
technique leaves as much soft tissue on the residual limb as possible in order to create a 
healthy stoma. The desired wound healing response is skin closure into the wound creating a 
permanent seal at the level of the bone.  This protocol requires a much shorter 6 week 
osseointegration unloaded healing period which has received a positive patient response. 
Developed in the 2000’s, the ITAP system is a one piece implant consisting of a smooth 
intraosseous titanium stem with a perforated, umbrella-shaped, hydroxyapatite (HA) coated 
flange (Figure 1.4c). The associated surgical technique lays the skin over the top of the flange in 
an attempt to minimize downgrowth and encourage epithelial soft tissue adhesion. The 
subcutaneous flange reduces relative interfacial movement between the epithelium and the 
implant [36].  This technique was developed as a biomimetic model of deer antlers [37].  
Verkerke et al. used FE analysis to assess bone failure and the bone-implant interface 
[38]. The study compared the OPRA system and the ILP Endo/Exo prosthesis. Results indicated 
that the porous ILP implant generated favorable bone strain energy density levels while the 
threaded OPRA implant generated lower peak bone stress levels. 
Both the OPRA and ILP systems are being marketed in Europe. A fourth implant, the 
Percutaneous Osseointegrated Prosthesis (POP) system is being developed at the University of 
Utah. It consists of a conical, ribbed bone implant region and a titanium P2 porous coated 
transcutaneous section (Figure 1.4d). Similar to the ITAP implant, the POP uses a subcutaneous 
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collar in an attempt to reduce interfacial movement. Clinical trials using the POP system have 
been set to begin within two years at the University of Utah. 
 
 
Figure 1.4: Existing transcutaneous OI implant systems: a) OPRA implant, b) ILP implant, c) ITAP 
implant, d) POP implant. Images reproduced from: a) Sahlgrenska Website [39], b) Endo-Exo 
Prosthesis DVD [40], c) Fitzpatrick et al. (2011) [41], d) Bloebaum et al. (2012) [42].  
 
1.3.5 Human Clinical Trials 
Over the last two decades, transfemoral surgical implantations have been performed on 
over 250 European amputees in a clinical environment [27, 28, 43]. A three-year follow-up of 
the initial 16 transfemoral patients treated with the OPRA system beginning in 1990 reported 
fourteen superficial infections and seven deep infections necessitating three (19%) implant 
removals [29]. A one-year follow-up of the initial 11 candidates treated in the United Kingdom 
(following the Swedish protocol) from 1997 to 2003 reported two (18%) implant removals 
secondary to infection [28]. A three year prospective study followed 39 patients treated in 
Sweden from 2005 to 2008. Implant infection was reported in 5% of cases at inclusion and 18% 
at follow-up [27]. From 1999 to 2009, 39 ILP systems were implanted in Lubeck, Germany [43]. 
Three implants (8%) were explanted due to deep bone and superficial soft tissue infections. 
Interestingly, in this study 37 of the 39 patients said they would undergo the implantation 
again. Summarizing the clinical trials, transcutaneous OI implants have reported 8-19% 
infection rates (Table 1.2). This is consistent with other permanent transcutaneous devices; 
a 
b 
c 
d 
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venous catheters, dental implants, and bone anchored hearing aids have shown an infection 
rate of 3-8%, 5-10%, and 23.9%, respectively [44, 45]. 
 
Table 1.2: Results from European transfemoral human clinical trials 
Clinical Trial Approximate Dates (Follow-up) Cases of Infection Explantation 
OPRA system 1990 (3 year) 14 superficial, 7 deep 3/16 (19%) 
OPRA system 1997-2003 (1 year) 2 total 2/11 (18%) 
OPRA system 2005-2008 (3 year) 2 at inclusion, 7 at follow-up Did not report 
ILP system 1999-2009 2 superficial, 1 deep 3/39 (8%) 
 
In 1999, an OPRA (Osseointegrated Prostheses for the Rehabilitation of Amputees) 
protocol was established to standardize rehabilitation treatments [22]. The study used the 
Questionnaire for Persons with a Transfemoral Amputation (Q-TFA) to report prosthetic use 
scores on a scale of 0 to 100. They found pre-OI scores to be wide-ranging with a mean score of 
51. A two year post-OI follow up of 18 subjects reported a mean use score of 83, a 32 point 
improvement in functionality. 
Webster et al. reported the perceptions of the transcutaneous OI procedure for 73 
current lower limb amputees [46]. One-third said they would consider the prosthetic option 
citing anticipations of prosthetic function (92%), improved walking ability (88%), prosthetic 
attachment (83%), and improved activity level (79%). Interestingly, only 50% of the amputees 
report decreased skin breakdown as a perceived advantage. Forty-two percent (42%) said they 
would not consider the option because of perceived disadvantages including infection (75%), 
potential for limited activity due to failure (65%), lengthy rehabilitation period (65%), and risk of 
bone fracture (63%). Significant lifestyle differences between individuals willing to consider 
osseointegration and those unwilling included living in a rural community, pain inhibiting daily 
activity, and detachment of their current prosthesis. The study concluded that infection 
prevention and rehabilitation efficiency need to be addressed in order to improve amputee 
perception of the transcutaneous OI method. 
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The transcutaneous OI prosthetic option is best suited for lower limb, AK, traumatic 
amputees with ample soft tissue coverage. Below knee amputees exhibit greater success with 
conventional prostheses and therefore would likely not prefer the higher risk transcutaneous 
option. A survey of 59 amputees reported daily prosthetic use in 96% of the BK compared to 
50% of the AK [47]. Further, a survey of 134 lower extremity amputees reported that BK 
amputees were significantly more independent than AKs [48]. Lower limb, AK, traumatic 
amputees account for roughly 300,000 Americans, or approximately 19% of the US amputee 
population.   
An interview with thirteen Swedish patients explored first-hand transcutaneous OI 
patient accounts [49]. Almost all patients responded favorably to the procedure describing the 
new method of attachment as “revolutionary” and “radical”. The authors grouped the patients 
into three classes of prosthetic acceptance: 1) Practical prosthesis, 2) Pretend limb, 3) A part of 
me. The practical prosthetic group felt it was a better tool than their previous prosthetic, but a 
tool nonetheless. One subject from this group stated, “This is perhaps 70 percent as compared 
to a real leg…being 100 percent and an old prosthesis is perhaps 25 percent.” The pretend limb 
group valued their new prosthetic as more than a tool, but still carried a burden of loss. The 
third group of patients seemed to accept their osseointegrated leg as an extension of their 
body. A subject stated, “I can feel when I put the foot down, so that I can feel the shock 
throughout the body – not in an unpleasant way but I feel it, and it gives me a positive 
experience of my body as a whole.” 
The internet has allowed further communication of inspirational personal accounts of 
the lifestyle that the procedure has returned to amputees. In 1993, a motorbike accident 
caused a man to lose his right leg [50]. For 15 years he used conventional prostheses and 
experienced a range of problems including stump soreness and soft tissue pain. He writes, 
“Living with this restriction became the norm and soon the changes to my daily life required to 
compensate for my disability became routine – the life of an amputee….” In 2008, he became 
the second recipient of the ITAP transcutaneous OI prosthetic. He was discharged from the 
hospital one week after surgery and trained with varying prosthetics for 18 months. In 2010, he 
climbed Mount Kilimanjaro, the largest mountain in Africa, with his ITAP prosthesis. He blogs 
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about his very active lifestyle and wrote, “In essence this procedure has given me my leg back!” 
Retrospective studies have previously shown that amputees using transcutaneous OI 
prostheses report an improved Health Related Quality of Life when compared to those using 
conventional prosthetics [21]. This type of first-hand account drives home the potential lifestyle 
overhaul that the transcutaneous OI option offers to amputees.  
 
1.3.6 Translational Animal Models 
While it is well documented via human clinical trials that transcutaneous OI implants 
have an 8-19% risk of infection in clinical application, there is an incomplete understanding of 
the human wound healing process. The lack of understanding is twofold: 1) the procedure was 
developed in a clinical setting geared towards an end product. This effort leads to retrospective 
clinical studies as opposed to hypothesis driven research questions. 2) The transcutaneous 
wound healing is a complicated process that requires a thorough evaluation of culture swabs, 
biopsies, and histology which is unfeasible to accomplish in a human clinical study. Translational 
animal models provide an opportunity to answer relevant questions about wound healing and 
infection around weight-bearing prosthetics. Over the last four decades, such models have 
attempted to improve the skin-implant seal around transcutaneous OI implants. 
 The first weight-bearing translational animal model was introduced in 1977. Lobb et al. 
investigated tissue integration into percutaneous prosthetics using a porcine model [51]. The 
group of 14 pigs was split into two, seven with nylon velour covering the transcutaneous 
section and seven with a double-velour Dacron fabric. They reported dry wounds with good 
subcutaneous adhesion and some skin adhesion over the first two weeks. By week three they 
observed soft tissue retraction resulting in minimal tissue adhesion by week five. By week ten, 
there was complete tissue retraction around the transcutaneous implants in all fourteen pigs. 
The study concluded that Dacron and nylon velours are not suitable for transcutaneous, weight-
bearing applications. In 1985, Hall et al. evaluated a Percutaneous Load-Bearing Skeletal 
Extension (PLSE) device using a weight-bearing caprine model [24]. This device anchored into 
the amputee using a large pin perpendicular to the residual bone leaving two transcutaneous 
holes. An external yoke was then attached to the pin. The authors hypothesized that the 
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interfacial bonds would not tear at the exit sites because there is greatly reduced stress away 
from the end of the limb. Goats with the PLSE devices survived without complications for up to 
14 months in the pasture until they “inevitably” became infected due to trauma or exposure to 
the elements. 
 Throughout the 1990’s and early 2000’s little work was published on the development 
of a translatable large animal model for transcutaneous OI prosthetics. The field has since seen 
a resurgence as a result of the progress demonstrated in the European human clinics. The FDA 
has stricter guidelines for device clearance, thus efficacy is usually first shown in an animal 
model. In 2008, Drygas et al. reported the successful implantation of a tapered, threaded 
titanium stem with a porous tantalum transcutaneous section into a dog model [52]. At a two-
year follow-up, the implant was infection free allowing the dog to run on the OI prosthetic leg. 
In 2011, Blunn and colleagues implanted the flanged ITAP prosthetic device in four dogs for 
limb salvage purposes [41]. They reported favorable bone and soft tissue integration with the 
animals returning to their pre-operative levels of ambulation. The sites were infection free from 
three weeks until approximately one year when the dogs died of unrelated circumstances. In 
2011, Bloebaum, Bachus and colleagues at the University of Utah investigated the use of the 
POP device in a 12 month ovine model [53]. The group concluded that an ovine model was 
feasible. Results indicated weight-bearing peaked at a maximum of 80% pre-operative levels 
over a 12 month time period. The group has since used the ovine model to investigate porous 
subcutaneous components, skin immobilization, and cortical bone response. In an evaluation of 
86 sheep, they compared porous and smooth subcutaneous surfaces [42]. Results showed zero 
of the 77 sheep with porous ingrowth surfaces and two of the eight sheep with smooth 
surfaces were infected at the nine month endpoint. They concluded that a porous subdermal 
barrier is advantageous for infection prevention. In an overlapping study using 37 sheep, 
Bloebaum’s team measured skin regression on a porous subdermal coating at six, nine and 12 
month time points [35]. The percent of sub-epithelial attachment was shown to decrease over 
the course of the study. The tissue regression was attributed to the high contact area of the 
porous surface. Results confirmed that micro-motion hinders soft-tissue implant fixation. Using 
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the ovine model as preliminary data, human feasibility trials for the POP device have been 
approved and are expected to begin in 2014 at the University of Utah.  
 
1.3.7 Relevant Transcutaneous Wound Healing Studies  
While relatively few attempts have been made at the development of a large weight-
bearing animal model for transcutaneous OI prosthetics, other permanent transcutaneous 
devices (e.g., venous catheters and bone anchored hearing aids) have been more thoroughly 
investigated in animal models. Much like transcutaneous weight-bearing prosthetic devices, 
catheters and hearing aids require an infection resistant seal at the protrusion of the 
transcutaneous device. The following describes relevant research literature investigating 
material, topography, treatments, biological coatings and surgical technique alterations.  
Researchers acknowledge that the success of transcutaneous implants is partially 
dependent on the material selection of the transcutaneous portion of the device. In 1974, Hall 
et al. used a caprine model to assess a nylon velour as a transcutaneous implant surface [54]. 
The team hypothesized that the material would eliminate the problems associated with 
marsupalization. The method was successful in creating a bacteriostatic seal but a “growth 
phenomenon” slowly extruded the implant. The study concluded that nylon or Dacron velour 
showed excellent results and eliminated the problems at the skin-implant interface. In 1977, 
von Recum et al. studied Dacron velour transcutaneous components in dogs, goats, and rabbits 
[55]. Results indicated that epidermal migration rate and connective tissue maturation differed 
among species. Further, the authors noted that percutaneous healing is a product of implant 
material histocompatibility, mechanical interfacial forces, and epidermal proliferative patterns. 
In 1990, Jansen et al. compared hydroxyapatite, titanium and carbon implants in a rabbit model 
[56]. It was importantly concluded that direct attachment to bone aids the longevity of 
transcutaneous devices. Further, no difference in tissue reaction as a result of the material 
selection was found at four or eight month endpoints. Notably, this was inconsistent with a 
1977 human case study by Mooney et al.  In this study, a skin-implant seal failed to develop 
with a smooth carbon surface at the transcutaneous interface after implantation in three 
amputees [57]. The devices were retrieved due to poor vascularization, mechanical factors, and 
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ultimately infection. In 1998, Kormos et al. hypothesized the use of a fine trabecularized carbon 
as the transcutaneous catheter material in a bovine model [58]. At the 30 day endpoint, 
epidermal downgrowth was minimized while connective tissue and neovascularization 
proliferated around the implant. The study concluded that the fine trabecularized carbon 
material is suitable for percutaneous devices. In 2009, Chou et al. compared porous tantalum 
and porous titanium as the material selection for the transcutaneous section [59]. There was no 
difference in rates of pin track infection between material groups. 
Studies have shown that infection rates also correlate to the surface topography and 
characteristics where the implant breaches the skin. In 1974, Winter et al. compared porous 
and nonporous titanium surfaces for the transcutaneous region of an implant [60]. His team 
concluded that at the 10-week post-implantation time point, the nonporous implants created 
an unstable, infection prone site while the porous implants allowed fibrous tissue ingrowth 
resulting in a stable junction. In 1981, Squier and Collins attempted to characterize the 
relationship between soft tissue attachment, epithelial downgrowth and surface porosity [61]. 
The team concluded that larger pores (up to 8.0 µm) induced greater soft tissue ingrowth. In 
1984, Grosse-Siestrup and Affeld reviewed natural percutaneous devices such as horns, hair, 
feathers, fingernails, hoofs, teeth, and antlers [62]. The group emphasized the importance of 
shifting mechanical stresses away from the skin attachment interface. They proposed the use of 
a subcutaneous flange to distribute the stresses induced by loading. In 1991, Chehroudi et al. 
investigated the effects of micromachined grooved surfaces on the epithelial downgrowth and 
tissue-implant seal at a microscopic level [63]. Electron microscopic analysis concluded that 
micro grooves can improve epithelial cell attachment. In 2002, Chehroudi et al. evaluated the 
effect of subcutaneous and percutaneous surface topographies on tissue integration in a rat 
model [64]. Results indicated that subcutaneous grooved surfaces improved tissue adhesion. In 
2005, Jansen et al. compared smooth and microtextured transcutaneous section of silicone 
catheters using a rat model [65]. They found epithelial downgrowth in all animals regardless of 
texturing, but concluded that the direction of the grooves can dictate ingrowth patterns.  In 
2007, Pendegrass et al. reported that smooth polished surfaces show significantly reduced 
infection rates by optimizing epithelial layer attachment in an in-vitro study [66]. 
 
18 
 
Contradictorily, in 2011, Bachus et al. showed that porous coated implants displayed tissue 
ingrown whereas the smooth implants were surrounded by a fibrotic capsule inhibiting a long-
term seal in a rabbit model [67]. The imperfect skin seal around the smooth implant induced an 
infection tract for the migration of infecting microorganisms; prompting a seven-fold increase 
in infection risk when compared to porous coated surfaces. Epithelial downgrowth was not 
correlated with implant type. In 2011, Blunn et al. assessed the use of silanized fibronectin 
(SiFn) on titanium surfaces to improve in vivo soft tissue attachment in an ovine model [68]. 
They concluded that SiFn surfaces resulted in better cell alignment and thus improved dermal 
attachment. Affeld et al. have recently developed a novel active skin-penetrating device for use 
in catheters [69]. Using a protective sleeve and active traction device, a permanent and stable 
ingrowth of skin cells is possible. The technique was shown effective at maintaining an 
infection-free skin barrier for 420 days in 10 goats.  
Animal studies have also considered surface treatments and coatings to combat 
bacterial isolates and promote soft tissue adhesion. In 1988, Jansen et al. implanted HA coated 
transcutaneous devices in the tibia and dorsum of guinea pigs and the tibia and cranium of 
rabbits [70]. Results indicated stable epidermal junction at the tibia and cranial implant sites 
but epidermal migration at the dorsal implant site. This was likely due to the amount of 
interfacial movement at the dorsal site compared to the other sites as numerous research 
groups have shown interfacial movement to be detrimental to seal formation. In 2006, Blunn et 
al. evaluated HA as a coating for the transcutaneous section in a non-weight bearing caprine 
model [37]. HA was applied to increase the surface porosity in an effort to tighten the seal 
between the implant and the dermal tissues. Results indicated that the treatment educed soft 
tissue attachment and supported the ingrowth of fibroblastic and soft tissues. The coating 
demonstrated reduced epithelial layer downgrowth and thus decreased rates of infection. That 
same year, Blunn and colleagues evaluated diamond-like carbon (DLC) and HA coatings in an 
ovine model [71]. At the 10-week endpoint, results indicated decreased bacterial colonies and 
biofilm formation with DLC implants and improved dermal and bone adhesion with HA 
implants. In 2009, Chou et al. assessed pexiganan acetate as a topical antimicrobial to prevent 
pin tract infection using a rabbit model [59]. They concluded that daily application of pexiganan 
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acetate correlated to a 75 percent reduction in infection rates. In 2010, Bloebaum et al. 
determined CSA-13, a broad spectrum antimicrobial, to be ineffective in preventing pin tract 
infections in a percutaneous pin wound site in a sheep model [72, 73]. The model was deemed 
overly aggressive, allowing for too much interfacial motion at the skin-implant interface. This 
work proposed that antimicrobials may be used as secondary barriers to infection, but 
ultimately skin attachment to the implants surface is most essential. In 2011, Bachus et al. 
showed Mesenchymal Stem Cell (MSC) treatments effective in improving skin attachment and 
early tissue integration on a porous metal percutaneous implant in a rat model [74]. Treated 
implants showed an early influx of cellular inflammatory infiltrates compared to the untreated 
implants. Epidermal downgrowth was observed in all implants and therefore uncorrelated to 
MSC treatment. That same year Bachus et al. showed MSC treated implants to be at lesser risk 
of infection compared to untreated implants in a bacterially challenged rat model [75]. Further, 
the group showed that MSC treatments stimulated tissue infiltration into the porous coatings 
and prompted a fortified seal from microbial infection.  
Finally, surgical techniques have been compared in animal models. In 1993, Jansen et al. 
evaluated a two-stage OI implantation procedure in a rabbit model [76]. At S1, HA coated 
titanium implants were implanted in the bone and the wound closed. At S2, three months later, 
a dense HA percutaneous portion was connected with the enossal part. At five months post-S2, 
there existed an effective percutaneous seal. However, the study was unable to irrefutably 
conclude that two-stage surgical procedures enabled greater success for transcutaneous bone-
anchored prosthetics than one-stage procedures. In 1996, the same team again evaluated one-
stage versus two-stage surgical techniques using titanium fiber mesh implants in twelve goats 
[77]. In each goat, they inserted a one-stage and a two-stage implant. A three month healing 
time was allotted for the two-stage implants. At four months post-S2, all implants were 
removed. While there was no difference in epidermal downgrowth between surgical groups, 
there was an enhanced inflammatory response found in the tissue inside the titanium mesh for 
one stage implants. The study concluded that the two-stage surgical procedure was 
advantageous for the incorporation of host tissues and transcutaneous devices. Jansen’s team 
realized the required three month healing time between surgeries was inhibitive from a clinical 
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standpoint. They further investigated the possibility of reducing the time interval without 
compromising the tissue response [78]. They implanted one transcutaneous device a week for 
six consecutive weeks into the back of nine goats.  Histological analysis indicated that an 
inflammatory response was active for two weeks, after which no difference was found. They 
concluded that a three week healing period between surgeries is sufficient for titanium mesh 
percutaneous devices.  
As outlined above, material selection, surface topography, biological treatments, and 
alterations to surgical techniques have shown varying degrees of success at promoting wound 
healing and preventing infection. One conclusion that has been consistent throughout 
experimentation is that interfacial movement is detrimental to the formation of an effective 
tissue-implant seal. Further overarching conclusions are difficult to draw because of the variety 
of animal models and study designs. A widely-accepted, translatable animal model would be 
beneficial in making the permanently attached endo-prosthetic more than a nearly-achievable 
orthopedic dream. 
 
1.3.8 Comparing Treatment Costs 
As a potential barrier to market, cost needs to be compared between traditional socket 
stump attachment and the transcutaneous OI method. In a study of 601 US amputees using 
traditional suction attachment, average initial hospitalization costs plus two years of health care 
costs, including prosthetics, for AKs were estimated at $110,039 [79]. The average lifetime 
health-care cost for amputees was $509,275. The personalized nature of the transcutaneous OI 
treatment, coupled with the increased surgical and recovery time will likely result in a more 
expensive treatment option. However, transcutaneous OI patients have shown increased levels 
of functionality. Their improved mobility could allow for a more complete return to work, thus 
improving their overall return on treatment investment. A more thorough understanding of 
cost will be important to evaluate the prospect of widespread clinical implementation for the 
transcutaneous OI prosthetic option. 
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This pilot study was designed around the execution of three specific aims: 1) animal model, 
2) infection, 3) wound healing. Specific Aim #1 evaluated the use of a porcine (pig) model in the 
assessment of transcutaneous OI prostheses. Specific Aim #2 assessed superficial and deep soft 
tissue infection around the transcutaneous OI implant. As discussed in chapter 1, infection rates 
of 8 to 19% have been reported in human clinical trials. Lowering the incidence of infection 
continues to be the primary goal of transcutaneous OI prosthetic research. Specific Aim #3 
evaluated wound healing around the transcutaneous implant. The animal model allows 
assessment techniques of wound healing that are not possible in a human clinical studies. 
Unless stated otherwise, this study was designed and executed by the author of this thesis. 
 
2.1 Specific Aim #1: Animal Model 
Specific Aim #1 evaluated the use of a porcine model to simulate the human 
transcutaneous OI condition. Previous non weight-bearing  and weight-bearing caprine, canine, 
and ovine models have considered material, topography, treatments, and surgical alterations in 
an attempt to expedite wound healing and ensure a skin-implant seal around transcutaneous 
OI implants.  The following important considerations regarding wound healing and infection 
have been overlooked when simulating the human transcutaneous OI condition in these 
previous animal models; 1) mimicking the physiological tissue response of a human, and, 2) 
creating a transcutaneous site with comparative soft tissue coverage.  
 It is to be noted that no studies have successfully tested a weight-bearing transcutaneous 
OI prosthetic device in a porcine model. Pig skin, like human, is relatively hairless, tightly 
attached to the subcutaneous tissue, vascularized by a cutaneous blood supply, and healed by 
means of epithelialization [80, 81]. The pig has been extensively utilized for superficial and deep 
wound healing studies and allows for ample soft tissue coverage following a lower limb 
amputation [82-84]. Sullivan et al. compared the translatability of different models in drawing 
conclusions about human clinical wound healing [80]. They found that porcine, small animal, 
and in vitro models are in agreement 78%, 53% and 57% of the time. Therefore, a porcine 
model appears to be the best tool for studying the wound healing of the transcutaneous OI 
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prosthesis. The work being presented is the first known in vivo large animal model 
physiologically similar to the human condition in which an axially-loaded, weight-bearing 
implant is currently being used. It was hypothesized that the pig will be capable of ambulation 
with a prosthetic leg within one week of surgery. Further, the pigs would achieve 80% pre-
operative weight-bearing on the operative limb by the end of the study. 
2.2 Specific Aim #2: Infection 
Specific Aim #2 assessed the presence of superficial and deep tissue infection 
surrounding a smooth transcutaneous implant. While superficial skin swabs can be obtained 
from human amputees, deep tissue evaluation is unfeasible in a human clinical study. The 
porcine model allowed for superficial bacterial swabs to be collected throughout the study and 
deep tissue samples to be collected at necropsy. Topical antibiotics were used throughout the 
study but oral antibiotics were only to be given after an infection was suspected. It was 
hypothesized that neither pig would develop an infection by the end of the study. 
2.3 Specific Aim #3: Wound Healing 
Specific Aim #3 evaluated the wound healing around a transcutaneous implant by assessing 
adherence of skin to implant, extent of epidermal down growth, and the types of cells present 
at the bone-skin-implant interface. Previous animal studies have assessed wound healing using 
similar measures but never on a pig model. It was hypothesized that the skin would not adhere 
to the smooth transcutaneous portion of the implant and that there would be a fully developed 
epidermal layer by the end of the study.  
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3.1 Specific Aim #1: Pig Model 
3.1.1 Animal Study Design 
Primary considerations when selecting the breed for the porcine model were 
availability, gender, age, weight, soft tissue coverage, and amount of hair on the skin. Male, 
nine months old, 80 pound Yucatan pigs were selected. Males were chosen to keep urine away 
from future wound wrapping sites. Animals needed to be at least nine months of age at the 
time of the surgery as this is when they are considered to be nearing skeletal maturity. This was 
important so as to limit growth-related cortical bone remodeling that could disrupt the integrity 
of the bone at the bone-implant interface. Eighty pounds was considered a manageable weight 
for handling. The Yucatan species also offered a minimal hair coating and substantial soft tissue 
coverage around the hind tibia that was comparable to the human amputee.  
Regulatory compliance, risk, and cost were the primary considerations for selecting the 
number of animals for the initial pilot study. Two animals were selected. The United States 
Department of Agriculture (USDA) and the Institutional Animal Care and Use Committee 
(IACUC) govern animal care policies. Regulatory standards advise that pigs be dual-housed, 
meaning that the animals had to be kept in the same room at the same time.  IACUC 
regulations required a week long acclimation period for the animals. The surgery on the first 
animal was performed at the end of this initial acclimation period. The animal’s recovery was 
closely monitored for three weeks as detailed in section 3.1.4 ‘Post-operative Recovery.’ At 
post-operative day 21 for the first animal, the surgery was performed on the second animal. 
The study continued for 35 additional days. The animals were sacrificed on the same day which 
corresponded to post-operative day 56 and day 35, respectively. These time points were 
chosen to give insight into wound healing and infection over the course of the healing process. 
3.1.2 Endo-prosthesis Design Process 
 The endo-prosthesis (i.e., implant) is defined as the portion of the prosthetic which is 
permanently attached to the host body. The endo-prosthesis design process was iterative as 
there has been no previous successful transcutaneous OI implant design for a porcine model. 
Implants were designed with four primary considerations: 1) bone fixation, 2) shape, 3) ease of 
implantation, and 4) transcutaneous design. The implant used in this study was designed 
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specifically for use in a 56 day porcine model. The final design is not meant to be directly 
applied or translated to a human model at this time.  
Immediate bone-implant fixation upon implantation was an important requirement 
because the pig would be trying to ambulate within minutes of waking up from surgical 
anesthesia. Threaded, porous bone ingrowth surface, and press fit were all considered as 
methods of mechanical fixation. Because the animal model required a single surgery, there 
would not be an unloaded healing period, and therefore porous bone ingrowth could not be 
effectively used as the method of bone-implant fixation. The Yucatan pigs had thick cortical 
bone in the distal tibia. To leverage this anatomical feature, threading was chosen over a press 
fit design.  
The shape of the implant determined how loads were distributed from the implant to 
the bone. Cylindrical, conical, and curved shapes were all considered as potential designs. A 
curved shape could ensure bone-implant contact with less bone removal. However, a non-
symmetric design would greatly increase the complexity and cost of the manufacturing process. 
A conical or tapered implant would allow better distribution of axial loads to the entire bone 
surface than a cylindrical implant. A taper was successfully applied to the early nylon and 
aluminum prototypes (Figure 3.1). However, the taper was felt to compromise the effectiveness 
of the thread engagement. Achieving threads over the full length of the tapered stem would 
require that the thread depth be at least as large as the taper depth. With a thread depth of 
only 0.78mm chosen for the implants, any functional taper prohibited full bone-implant 
engagement at the most proximal threads. A taper was considered again in the design of the 
implant for pig #2 but dismissed because of its constraint on the ability to put a flat at the 
proximal end of the implant. As discussed in section 3.1.3 ‘Final Endo-Prosthesis Design,’ the 
flat increases the rotational stability of the implant. If the flat was included on a tapered 
implant, the flat would only be able to be as wide as the smallest portion of the taper. The flat 
provides necessary torsional stability that was considered more important than the conical 
shape and therefore a cylindrical implant was chosen. Further, the cylindrical shape simplified 
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the surgical procedure as a custom tapered reamer would have had to be manufactured if the 
conical shape had been chosen.  
An unfluted implant was initially used in the cadaver practice surgeries. However, the 
torque required to screw in the implant was unachievable by hand. A single full-length flute was 
incorporated and tested in a subsequent cadaver surgery. The implant performed better at 
cutting through the bone. Cutting flute surface area was increased by replacing the one 100 
percent-length cutting flutes with two 60 percent-length cutting flutes in the implants for pig #1 
and pig #2. The flutes were successful in tapping the bone and easing insertion of the implant 
by hand. As discussed in section 5.5.1 ‘Future Endo-prosthetic Design,’ an alternative cutting 
flute pattern should be incorporated to increase holding strength. 
A porous coating and smooth surface were both considered as the potential surface for 
the transcutaneous section. As detailed in section 1.3.7 ‘Relevant Animal Studies,’ much of the 
literature has shown that porous surfaces are advantageous for inducing skin-implant 
incorporation. However, the smooth transcutaneous surface has been better represented in 
human clinical trials as approximately 240 out of the 250 European amputees with 
transcutaneous OI weight-bearing prosthesis have either the OPRA or ILP implants. Despite the 
success of the human clinical trials, there has been very little translational animal research 
using a smooth transcutaneous portion. By preventing the skin from incorporating with the 
implant, it was theorized that the epidermal layer would migrate towards the bone to form a 
skin-seal at that location. Attempting to create a biological tissue interface with skin and bone is 
advantageous to the potential interface created with skin and implant. Therefore, the final 
implant design for the porcine studies used a smooth transcutaneous section of the implant in 
an attempt to create a relevant animal model for the most common of the European human 
implants. 
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Figure 3.1: Iterative endo-prosthesis design process. a) Practice threading with nylon, b) 
Practice taper with nylon, c) Practice threading and taper with aluminum, d) Practice coarse 
thread pitch with aluminum, e) Practice exo-prosthesis attachment site with aluminum, 
attachment design pictured was not used again, f) Practice machining with titanium, g) Practice 
full implant with titanium, h) Full-length cutting flute with aluminum, i) Titanium implant used 
on pig #1 with two half-length cutting flutes on threads, j) Titanium implant used on pig #2 with 
two half-length cutting flutes on threads and flat with holes at proximal end. 
 
3.1.3 Final Endo-prosthesis Design 
The final endo-prosthesis was a one piece construct consisting of a shaft, 
transcutaneous collar, and exo-prosthetic attachment site. Pre-operative anterior-posterior and 
medial-lateral tibial radiographs were taken for each animal. Using the radiographs, the surgery 
was planned. The length of the implant was custom fit for each animal by first determining the 
amount of distal bone to remove. This equated to approximately 25% of the bone, with the 
intention of opening up the medullary canal for implant insertion. Shaft length was then 
determined from the radiograph. The most proximal tip of the shaft was positioned to extend 
just beyond the medullary canal, distal to the metaphysis.  Endo-prostheses shaft diameters 
e f g h i j b c d a 
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and lengths were custom fit for each animal using their respective periosteal and endosteal 
diameters. Equation 3.1 was optimized after numerous cadaveric practice implantations.  
 
Equation 3.1: Determining the implant shaft diameter. 
Implant shaft OD = [(P-E) x 0.53] + E   
where OD = Outside Diameter, P = Periosteal diameter, E = Endosteal diameter 
 
The implant for the first pig was cylindrical, threaded, and self-tapping to provide for 
secure immediate fixation and ease implantation (Figure 3.2a). A 7/20-20 thread was used for 
the final implants. The 7/20” nominal diameter was selected based upon the cortical diameter 
and thickness. The 20 tpi was chosen because finer thread pitches have been shown to increase 
the bone-implant contact area and primary stability of the implant [85].  An additional flat at 
the proximal end of the threads was incorporated into the implant for the second pig to resist 
rotation (Figure 3.2b). Two holes were drilled through the surface of the flat to incorporate 
bone cement as an additional method of rotational stability. The flats were oriented on the 
same sides of the implant as the cutting flutes.  The transcutaneous collars, which permanently 
breech the natural skin barrier, were smooth to deter direct skin-implant adhesion. The distal 
end of the endo-prosthesis was fashioned to allow quick donning and doffing of the exo-
prosthesis. A clamp secured the exo-prosthesis to the implant in the axial and radial directions. 
The implants were custom manufactured by the Orthopedic Research Lab at the University of 
Kansas Medical Center from a 5/8” diameter round bar of medical grade 5, Ti-6Al-4V alloy. A 
medical grade titanium alloy was chosen for biocompatibility. A detailed engineering drawing 
for the modified endo-prosthesis used on the second animal can be found in Appendix 1.  
 
Figure 3.2: a) Endo-prosthesis for pig #1, b) Endo-prosthesis for pig #2. As pictured, the right 
threaded end of the implant is the side which goes into the bone. The smooth middle section is 
the transcutaneous piece. The left end with the smaller diameter is the portion onto which the 
exo-prosthesis is clamped.  
a b 
 
30 
 
3.1.4 Endo-prosthesis Manufacturing Process 
The prototypes and final implants were designed so that they could be manufactured in 
the Orthopedic Research Laboratory at KUMC (Figure 3.3). This was considered necessary to 
minimize cost and manufacturing turnaround time. The initial prototypes were made from 
nylon to demonstrate and practice specific features. The material was then changed to 
aluminum to create functional prototypes for cadaveric surgeries. The final implants were made 
from titanium so they could be used in the in-vivo animal model.  
The final implant was made from a 5/8” diameter rod of medical grade 5, Ti-6Al-4V 
alloy. The bar was cut using a horizontal bandsaw longer than the final implant length so it 
could be gripped in the vice of the lathe. The implant was placed in the lathe and a center hole 
was drilled on the proximal end for the lathe center support. Reference lines for the bone, skin, 
and exo-prosthetic attachment sections were touched off on the implant surface. The different 
sections were turned down to their respective diameters (Appendix 1).  The portion to be 
threaded was taken to the nominal diameter of the threads. The implant was removed from the 
lathe and moved to a mill. Cutting flutes were made in the portion to be threaded using an end 
mill. The implant was moved back to the lathe and the threads were cut into the bone section 
using a 16ER20UN threading tool. The excess lengths from both ends of the implant were cut 
off using a bandsaw and the ends were faced off on the lathe. The implant was moved back to 
the end mill to put the flat and holes on the proximal end of the bone section.  
   
Figure 3.3: Important steps in the manufacturing process of the endo-prosthesis. a) Implant in 
the lathe after each section has been turned down to the respective outside diameters, b) 
Implant in the end mill after the cutting flutes have been made, c) Threading the bone section 
of the implant in the lathe.  
a 
 
b 
 
c 
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3.1.5 Exo-prosthesis Design Process 
The exo-prosthesis is defined as the portion of the prosthesis which is not permanently 
attached to the host body. Exo-prosthesis design was iterative as examples of previous swine 
prosthetic use were non-existent. Design attempts began by trying to make the exo-prosthesis 
closely resemble the shape of the natural leg. The amputation procedure included the removal 
of both the tibiocalcaneous joint and the metatarsal-tarsal joint. These joints are crucial to 
creating the forward motion of healthy gait. In order to simulate the joints post-amputation 
using a static prosthetic, it was thought that the foot positioning should remain the same 
relative to the tibia. To determine maximum strength requirements, a situation in which the 
animal was standing on its hind legs with half of the body weight transferred through the 
prosthetic was considered. Therefore, all components of the bracket construct would need to 
support half of the body weight of an animal weighing approximately 80 pounds. To achieve a 
factor of safety of 2.0, the construct would need to support 80 lbf or 356N.   All prosthetic 
components and mechanical test fixtures were manufactured in the Orthopedic Research 
Laboratory. 
Adjustability was thought to be essential so that the leg and foot positioning could be 
adjusted per animal size. This was a difficult task to accomplish because the exo-prostheses 
were being made before the delivery of the animals. Angles and lengths of the prosthetic 
components were initially selected based on cadaveric dissections and radiographs so that the 
foot would strike the ground at the 
normal ground contact point 
relative to the animal’s body. The 
weakest point of the prosthesis 
construct was assumed to be the 
hinge as it was the adjustable 
component. The initial exo-
prosthetic bracket design used a 
two-legged housing that 
incorporated a set screw 
Figure 3.4: a) Healthy porcine stance, b) Initial rigid 
exo-prosthetic design with adjustable angles (as 
indicated by arrows) and length (by replacing the metal 
bar in between the brackets).  
 
a 
 
b 
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attachment to the implant and a hinge joint that connected to the aluminum member that 
comprised the length of the leg (Figure 3.8a).  The joints could be fixed at any angle in two 
planes by tightening the nuts and set screws (Figure 3.4). The length could be adjusted by 
exchanging the rectangular bar or ‘metatarsal’ in between the joints. The prosthetic foot was 
attached by a second similar bracket. The adjustability in angulation was the design factor that 
largely drove this initial design.  
Mechanical testing was used to determine the 
strength of the initial exo-prosthetic joint construct. 
An axial pull test was used to determine the point of 
failure for the hinge construct (Figure 3.5). The tests 
were run in displacement control at a rate of 
1mm/sec over a distance of 10mm. Data was 
captured at 100 Hz. The joints were tightened by 
hand to approximately 80 N-m using a torque 
wrench. Data is presented as a force versus 
displacement curve. A reference slope was 
calculated from the initial linear section of the curve 
for each trial.  The point of failure for the bracket 
construct was calculated by comparing a moving window of slopes to the reference slope. 
Failure was defined as a 50% change in slope between the moving window and the reference 
slope. This method was useful to determine the point at which the static friction of the bracket-
member construct was compromised. This was considered the point of failure because if the 
construct loosened on the animals, they would no longer be able to walk. Every fifth data point 
was used in the calculations to increase the sample range and decrease the effect of noise. The 
point of failure was averaged over five trials to determine a mean point of failure for the 
bracket. Results indicated that the average point of failure for the two-leg hinge construct was 
94.0N (Figure 3.6). This was only 26% of the predicted 356N that was required to support half 
the weight of the animal with a safety factor of 2.0.  
Figure 3.5: Mechanical test set-up 
for the two-leg hinge joint 
mechanical test. Tests were run in 
displacement control at a rate of 
1mm/sec over a distance of 10mm.  
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Figure 3.6: Results from the mechanical test for the two-legged bracket. The average point of 
failure over the five trials was 94.0N. 
 
It was theorized that the two-legs of the housing were hindering the initial static friction 
effect of the slip washers. Therefore, a leg of the hinge was removed to increase the 
compressive strength of the slip washer, bolt, and nut combination and thereby increase the 
point of failure for the prosthetic joint (Figure 3.8b). A one-leg hinge was evaluated with the 
same axial pull test. The hinges were again tightened prior to testing to approximately 80 N-m 
using a torque wrench. Results indicated that the average point of failure over the five trials for 
the one-leg hinge construct was 125N (Figure 3.7). Again this was insufficient as it corresponds 
to 35% of the predicted 356N that was required to support half the weight of the animal with a 
safety factor of 2.0. 
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Figure 3.7: Results from the mechanical test for the two-legged bracket. The average point of 
failure over the five trials was 125N. 
 
Removing a leg of the hinge only slightly increased the force required to overcome the 
initial static friction of the washer, bolt, and nut construct. The hinge performed better in Trial 4 
because the bolt, nut, and slip washers were replaced with new ones before the test. On this 
trial, the initial slip occurred at about 278N compared to an average of 87N for the other four 
trials. New hardware was to be used on the final prosthesis but accounting for wear over time 
in the animal model, this performance could not be relied on and a new bracket design was 
necessary. At this time, the set screws were also reevaluated because they took too long to 
tighten and release and required a separate hex key to operate.  
The third iteration of the bracket replaced the set screws with a clamp (Figure 3.8c). The 
clamp was quicker and easier to fix and unfix.  Further, it provided much greater initial static 
friction because of the larger contact area between the bracket and implant. The slot beneath 
the clamp bolts was used to constrain the implant from pulling out axially. The slot was 
chamfered so that the implant could be marked and its radial position could be checked at 
dressing changes. This allowed the observer to check whether the implant was unthreading 
from the bone or the implant was spinning within the bracket. The adjustable hinge joint in the 
first designs was replaced with a fixed bolt design. The fixed bolt greatly exceeded the 356N 
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necessary to achieve the 2.0 factor of safety as it would require the bolt breaking. The holes for 
the bolts could be drilled at any angle in the bracket but the construct was no longer adjustable 
after the bracket was manufactured.  Limiting adjustability to increase strength was considered 
a necessary tradeoff. The implant diameter was increased, causing the size of the bracket to be 
increased (Figure 3.8d). An additional hole was also drilled to enable two attempts at aligning 
the prosthetic foot. This prosthetic bracket was used as part of the rigid exo-prosthetic on the 
first animal but the angles were too extreme for correct foot positioning (Figure 3.9a). As a 
result, the first animal improperly loaded the prosthetic limb, nearly fracturing its operative 
limb. The bracket was replaced with the one pictured in Figure 3.8e. This bracket used clamps 
at both the top and bottom. A cylindrical aluminum ‘metatarsal’ was clamped into the bottom 
replacing the bolts and imperfect hole alignment.  
 
Figure 3.8: Iterations of the bracket for the endo-exo prosthetic attachment: a)Two-leg hinge, 
b) One-leg hinge, c) Small clamp with fixed bolts, d) Large clamp with fixed bolts, e) Two sided 
clamp. The large clamp with fixed bolts was attempted but the angles determined to be too 
extreme. The two sided clamp was used for the first animal throughout the later stages of the 
in-vivo animal model. 
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The bracket pictured in Figure 3.8e was used in conjunction with a peg after the training 
prosthesis was removed for the first animal as can be seen in Figure 3.9d/e. The straight peg 
aligned the prosthetic foot slightly behind the natural foot position for the animal. The bracket 
was not modified for this animal because it shortened the moment arm that was responsible 
for the implant unthreading as is discussed in section 4.1.1 ‘Animal Observation.’ The implant 
was modified for the second animal as described in section 3.1.3 ‘Final Endo-prosthesis Design’ 
so that unthreading was not a concern. The bracket could then be angled for the second animal 
so that the alignment of the foot could be corrected. The bracket was also modified to 
incorporate a threaded insert at the bottom (Figure 3.9d/e). The clamp at the top still allowed 
radial alignment and the threaded insert allowed connection of a fiberglass all-thread to secure 
the foot. A nut was tightened to the underside of the bracket to secure the construct.  
 
Figure 3.9: Exo-prosthesis design. a) Initial rigid exo-prosthetic, b) Retention cup, c) Foam 
training prosthesis, d) Peg with silicone foot, e) Peg with polyethylene/foam foot, f) Angled 
bracket with hard foam foot, f) Exo-prosthetic pictured in ‘f’ wrapped in medical tape, h) Exo-
prosthetic pictured in ‘g’ on animal #2, also notice retention cup protecting the wound site. 
a b c 
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The prosthetic foot was also adjusted throughout the design process to meet the needs 
of the animals. Immediately after surgery, a rigid exo-prosthesis and foot was attached to the 
first animal (Figure 3.9a). The prosthesis was quickly determined unsuitable for the animal 
model and replaced with only a retention cup that was used to protect the wound site. The 
retention cup was packed with gauze and secured directly to the implant for the initial non-
weight bearing healing period (Figure 3.9b). It was made of a hard plastic and perforated to 
allow the wound to be exposed to air. The top of the retention cup was secured to the residual 
limb with medical tape and held from below by the exo-prosthetic clamp. The retention cup 
was cleaned and the gauze replaced at dressing changes. The cup was left to protect the wound 
on both animals for the entirety of the study. The training prosthetic was attached at day six for 
the first animal and was not used on the second animal for reasons described in section 4.1.1 
‘Animal Observation’ (Figure 3.9c). The training prosthetic was meant to provide support at the 
natural leg height while limiting the length of the moment arm to reduce torque on the 
implant. The foot attached to the peg for the first animal was initially made from silicone 
(Figure 3.9d). The repeated loading of the prosthetic caused the metal peg to pierce the 
silicone. The silicone foot was replaced with a composite polyethylene and foam meant to 
mimic the pliability of a natural foot while withstanding the potential deformation caused by 
numerous loading cycles (Figure 3.9e). The exo-prosthesis was designed so that the feet could 
be quickly replaced using a bolt on the underside of the foot that threaded into the prosthetic 
leg. The second animal used the angled bracket with a foam foot exo-prosthetic (Figure 3.9f/g). 
The bracket could be clamped to the implant at any rotational angle to align the prosthetic foot 
with the pig’s natural foot-ground contact point. The prosthetic leg was made of aluminum and 
fiberglass to keep the leg lightweight while maintaining material strength. This was attached at 
day two for the second animal and used throughout the entirety of the study (Figure 3.9h). 
After the failure of the initial rigid exo-prosthesis, the overall trends in the remainder of the 
exo-prosthetic foot design were from larger to smaller contact areas and pliable to stiffer 
foams. The combination of these variables allowed the leg to adjust to the needs of the animal 
based on gait observation. The final exo-prosthetic design for both animals simulated the 
natural foot as much as possible. The exo-prosthesis incorporated interchangeable and 
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replaceable parts wherever possible to adjust angle and height while easing donning and 
doffing of the prosthesis.  
3.1.6 Surgical Technique 
The following describes the surgical procedure for the first pig. IM Ketamine (15-
25mg/kg), IM Midazolam (100-500mg/kg), and transdermal Fentanyl (100µg/hr) were 
administered as pre-anesthetic medications, Bupivacaine (4.4mg/kg) was administered as an 
epidural, and anesthesia maintained with oxygen and isoflurane (1-2%) by house veterinarians. 
A complete list of medication used intraoperatively and during recovery can be found in 
Appendix 2. The pig was placed in dorsal recumbency to enable the surgical approach. A 
complete listing of surgical supplies can be found in Appendix 3 and detailed surgical protocol 
can be found in Appendix 4. The left hind limb was prepped using a chlorhexidine surgical scrub 
and the site was sterilely draped. A longitudinal fish mouth incision was made anteriorly, 
proximal to the ankle joint. Dissection was performed with electrocautery before and after the 
bone amputation (Figure 3.10a). Neurovascular bundles were clamped, divided and tied off 
with 3-0 silk sutures in standard fashion. Dissection was carried down to bone along the medial 
incision. The bone was cut 3cm proximal to the anterior skin incision. The fibula was cut and 
rasped proximal to the tibia. The tibia’s medullary canal was reamed to 8mm, then 9mm. The 
implant was partially threaded into the canal to initiate the cutting flutes and then unthreaded. 
The muscle layer was closed with a 3-0 vicryl suture by pulling the muscles posterior to anterior 
over the end of the residual tibia and fibula. The skin was then closed with 3-0 nylon. A k-wire 
was sent through the skin to locate the medullary canal. A custom 2.2mm circular punch was 
used to pierce through the skin and muscle layer down to the level of the bone. Medium 
viscosity antibiotic bone cement (DePuy Orthopaedics, Inc., Warsaw, IN) was injected into the 
medullary canal and the implant threaded in (Figure 3.10b) Hemostasis was maintained 
throughout the entire procedure. The wound was sterilely dressed and immediate post-
operative radiographs were taken to ensure initial fixation of the threads (Figure 3.11b/c). The 
implant was flush against the tibia’s distal end as evidenced by the radiograph. The animal 
woke from general anesthesia uneventfully. 
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The same procedure was used for the second pig with three changes. First, the right 
hind limb was the operative leg as opposed to the left. The leg was changed because post-
operative gait analysis from the first pig demonstrated that the implant was likely unthreading 
as a result of the pig’s gait. With right hand threads, each step with the right leg rather than the 
left would theoretically tighten the screw rather than loosen it. Second, the medullary canal 
was only reamed to an 8mm diameter on the second pig because a smaller diameter implant 
was used. Finally, the implant design with the flat on the threads was used as opposed to the 
symmetric implant. This design feature was meant to engage the bone cement for increased 
rotational stability. The post-operative radiograph for the second pig showed that the implant 
was not completely flush against the tibia’s distal end. There was soft tissue that was unable to 
be removed before implant insertion, leaving an approximate gap of 2mm between the implant 
and bone.  
 
 
Figure 3.10: Animal surgery. a) Dissection with electrocautery after amputation. The amputated tibia can 
be seen as the white bone in the middle of the limb, b) Operative leg after skin closure and implant 
insertion.    
 
 
 
 
 
 
 
 
 
 
a b 
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Figure 3.11: a) Post-operative dressing schematic, b) Pig #1 radiograph,  c) Pig #2 radiograph. 
Notice the implant was not completely threaded in on the second animal due to soft-tissue 
interference while the bone cement dried during surgery. 
 
3.1.7 Post-operative Recovery 
The hours immediately following surgery were critical. Each animal was observed for 
clinical signs of distress including: hyperactivity, restlessness, nervousness, salivation, anxious 
facial expression, self-mutilation, hypo-activity, listlessness, reluctance to move or get up, 
altered gait, favored body part, excessive licking, aggressiveness when approached or touched, 
unprovoked vocalization, vocalization when touched, reduced intake of water and food, and 
dull, dirty or greasy changes in skin or hair coat. Clinical signs of a pig affected by ulcers include 
vomiting, rigid stance, melena, a loss of appetite and reduced growth rate.   
Pig #1: The stoma was coated with a triple antibiotic and a rigid exo-prosthesis was 
attached to the distal implant immediately following surgery. As the pig awoke from surgical 
anesthesia, his weight was supported fully by a panepinto sling (Figure 3.12). The pig appeared 
agitated by the sling but ate and drank within 90 minutes of surgery. The pig was lowered to 
allow partial weight-bearing and then the sling was removed to allow full weight-bearing within 
2.5 hours of surgery. The pig thrashed upon being initially lowered, resulting in high forces 
being applied to the long moment arm of the rigid prosthetic leg. The high torques experienced 
during immediate recovery were cause for concern but precautionary radiographs did not 
indicate fracture. 
a b c 
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The rigid exo-prosthesis was removed and the stump wrapped securely to the animal’s 
midsection using a compression wrap. From day one to three, the pig stayed fairly prone and 
then gradually transferred to standing and walking on three legs. At day four, the leg was 
released from the compression sling and a plastic retention cup fashioned in the Orthopedic 
Research Lab was packed with gauze and secured to the endo-prosthesis. It was thought that 
the animal would continue ambulation on three legs, but instead the pig immediately altered 
its gait so it could load the limb via the short exposure of the implant. The training prosthesis 
was then fashioned in the Orthopedic Research Lab and attached at day six restoring full length 
to the limb. As time progressed, the shape and material of the prosthetic was adapted due to 
changes in the behavior of the animal. The final design of the prosthetic is detailed in section 
3.1.2 ‘Endo- and Exo-prosthesis Design’. 
Pig #2: The stoma was coated with a triple antibiotic immediately following surgery. The 
operative leg was immediately wrapped in roll gauze for padding. As the pig awoke from 
surgical anesthesia, his weight was supported fully by a panepinto sling (Figure 3.12). The pig 
was lowered to allow partial weight-bearing and then the sling was removed to allow full 
weight-bearing within three hours of surgery. As the pig became more active, the bandaging fell 
off, compromising the sterility of the wound site. The wound was cleaned, layered with gauze 
pads, and secured with the placement of the retention cup seven hours after the initial surgery. 
The top of the retention cup was taped around the residual limb. The retention cup was held on 
axially by a clamp. The pig began loading the bone immediately, using the implant as a 
prosthesis. On day two, the final full-length exo-prosthesis was attached. Exo-prosthetic 
attachment occurred four days earlier than with the first animal because adjustments were 
made to the exo-prosthetic design. The training prosthesis was the first design attached instead 
of an unsuitable rigid exo-prosthesis as was the case with the first animal. 
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Figure 3.12: Post-operative recovery. a) Recovery cage setup, b) Panepinto sling with pig #1 
immediately post-surgery. Pictured with rigid exo-prosthesis attached to the operative left hind 
limb. This was just before the pig thrashed, causing the rigid prosthesis to be removed. It was 
replaced with the retention cup and then the training prosthetic and eventually the full length 
peg as discussed in section 3.1.4.  
 
3.1.8 Post-operative Care 
Both animals were monitored daily. The stoma was coated with a triple antibiotic 
immediately following surgery. Every second day after surgery, the pigs were anesthetized 
using oxygen and isoflourine (2.0-2.5%) to allow for each dressing change. Daily dressing 
changes were not done because daily anesthesia would have been too much for the animal. At 
dressing changes, the superficial transcutaneous skin-implant interface was unwrapped, 
swabbed, cleaned with 1.5% hydrogen peroxide and saline, coated with triple antibiotic, 
rewrapped, and secured with the retention cup (Appendix 5). A hydrogen peroxide solution was 
used to decrease bacterial count and rid the wound of inhibitive agents such as dried blood. 
Infection was presumed to be the potential primary failure mechanism. Therefore, the intent 
was to keep the wound as clean as possible and thus minimize bacterial count [86]. It is to be 
noted that the 1.5% hydrogen peroxide solution killed both normal flora and pathogens without 
discrimination. This solution was replaced with a soap and water solution at 44 and 26 days, 
respectively.  Skin sutures were removed on both animals at 14 days post-surgery. Pigs were 
sacrificed at 56 and 35 days after surgery, respectively. As explained in section 3.1.1 ‘Animal 
a b 
 
 
43 
 
Study Design,’ the difference in sacrifice times was necessary to comply with IACUC regulations 
regarding the housing of multiple pigs.  
3.1.9 Force Plate Data Collection  
Force plate data collection and data analysis was primarily designed and executed by 
another student in the KUMC Orthopedic Research Laboratory. A 12’ x 3’ platform was built 
around a force plate (Bertec Corporation, Columbus, OH). The animals were guided on a leash 
at a steady walking state over the platform (Appendix 6). The force in the z direction was 
recorded on all trials in which the operative limb struck the force plate. The maximum force in 
the z direction was averaged across trials for each day and data analysis was reported as a 
percentage of animal body weight.  This data is included in this thesis only to demonstrate that 
the animals were loading the operative limb throughout the study.  
 
3.2 Specific Aim #2: Infection 
3.2.1 Microbiological Evaluation 
Bacterial swabs were taken prior to surgery to record baseline microbial flora on the 
lower limb. Swabs of the surgical incision site were taken every 48 hours until the incision 
healed at eight days post-surgery. Swabs of the transcutaneous skin-implant interface were 
taken every 48 hours for two weeks post-operation, and then every 72-96 hours for the 
remainder of the study. Swabs were preserved in Amies Transport medium and sent to St. 
Luke's Microbiology Laboratory (Kansas City, MO) for evaluation within 72 hours of collection. 
The swabs were only cultured to detect the presence of bacteria, unless Pseudomonas 
aeruginosa or Staphylococcus aureus were isolated in which case a sensitivity analysis was also 
done. 
3.2.2 Soft Tissue Biopsy Evaluation 
 Soft tissue samples from the operative limb were collected at the bone-skin-implant 
interface just proximal to the transcutaneous site at necropsy. Samples were preserved in 
saline and sent to St. Luke’s Microbiology Laboratory (Kansas City, MO) to assess the presence 
of a deep tissue infection. 
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3.3 Specific Aim #3: Wound Healing 
3.3.1 Gross Observation 
  The wound site was visualized at each dressing change. Clinical signs of infection 
include smell, excessive and unusual discharge, inflammation at the surgical site, and increased 
temperature. Upon removal, gauze pad exudate was assessed with the assistance of the 
veterinary staff to determine whether it was excessive or unusual. Palpation allowed an 
assessment of inflammation. A thermometer allowed an assessment of body temperature and 
was taken daily if an infection was suspected. Pictures were taken every 48-96 hours to 
document the wound site.  
3.3.2 Histological Evaluation 
 At necropsy, the operative hind limbs were harvested for fixation and further 
histological tissue evaluation (Appendix 7). The implant was unthreaded and removed. Tissue 
adhesion was evaluated during implant removal. The tissues of interest were fixed in 10% 
buffered formalin, processed and infiltrated with an automatic tissue processor in a routine 
manner (Tissue Tek VIP 2000, Sakura, Torrance, CA) and embedded in paraffin (Appendix 8). 
Specimens containing bone were decalcified with RBD decalcifying solution (American Master 
Tech Scientific, Lodi, CA). Tissue was sectioned to a thickness of 5 microns using a microtome 
(Shandon Finesse ME+, Thermo Fischer Scientific, Walthan, MA). Slices were stained with 
Hematoxylin and Eosin (H&E) and examined microscopically (Appendix 9). Histologic evaluation 
allowed assessment of epithelial migration patterns and evaluation of soft tissue-implant 
adherence.  
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4.1 Specific Aim #1: Pig Model 
4.1.1 Animal Observation  
Both pigs ambulated on three legs without substantial complications during the time 
their operative leg was wrapped in a compression sling. In both cases, the pigs immediately 
loaded a prosthetic when it was attached and quickly readjusted to a four limb ambulation 
pattern. By post-surgery day six and three respectively, both pigs were loading the operative 
limb while standing and walking with a minor limp. The first animal thrashed with the rigid 
prosthesis when the sling was initially lowered. After that rigid prosthesis was detached, none 
of the other clinical signs of distress were observed for either pig. The animals continued to 
load the transcutaneous OI prostheses throughout the entirety of the 56 and 35 day study, 
respectively (Figure 4.1). Detailed gait monitoring of both pigs can be found in Appendix 10. 
Pig #1: The training prosthetic was attached at day six. The training prosthetic was 
replaced with a full length prosthetic at day eight. The pig demonstrated healthy ambulation 
patterns from day six to day 23. The implant was first noticed unthreading from the bone at day 
21. The bone cement was compromised but the implant showed no degree of toggle and could 
not be threaded or unthreaded by hand. The implant unthreaded approximately one eighth 
turn, or 1/160 of an inch in the axial direction every day. At day 23, the animal began stretching 
the operative leg backwards on occasional steps. A gait study at day 29 suggested the pig was 
loading the operative leg at 46% of its total body weight (BW). At day 32, the angled bracket 
was replaced on the exo-prosthesis with a straight bracket. The change was meant to decrease 
the length of the moment arm and therefore limit the available torque to loosen the implant. 
This was successful as the pig seemed to load the peg normally and the endo-prosthesis 
stopped unthreading. A gait study at day 43 suggested the pig was loading the operative leg at 
41% BW. A final gait study at day 55 suggested the pig was loading the operative leg at 39% 
BW. The slight decrease in weight-bearing was assumed to be due to the unthreading of the 
implant from the bone. The pig’s weight fluctuated between 79 and 93 pounds over the 
duration of the study. 
Pig #2: The pig demonstrated comfortable three-legged walking patterns from day one 
to day two. Occasionally the pig would alter its gait to load the implant, using the implant as a 
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very short prosthetic. The training prosthetic was deemed unnecessary because the pig was 
loading the implant at day one. A full length prosthetic was attached at day two. The pig 
gradually decreased its weight-bearing on the operative limb until the study’s end at day 35. A 
gait study at day 13 suggested the pig was loading the operative limb at 48% of its total body 
weight. At day 14, the animal began stretching the operative leg backwards on occasional steps 
similar to the stretching movement described in pig #1. A gait study at day 34 suggested the pig 
was loading the operative leg at 42% BW. The implant for pig #2 demonstrated secure bone 
fixation without toggle or loosening throughout the entirety of the study. The slight decrease in 
weight-bearing followed the pattern seen in the first animal but the reason for the decrease is 
unexplained by the theory used in the first animal as the implant-bone interface was fixed 
throughout the study in the second animal. The pig’s weight fluctuated between 79 and 87 
pounds over the duration of the study. The percentage animal weight-bearing is summarized 
for both animals in Table 4.1. 
 
Table 4.1: Percentage animal weight-bearing (%BW). The maximum Fz component of the pig 
gait was averaged over all successful trials. The percentage of body weight that the pig loads 
the operative limb is reported as percentage weight bearing. Notice pre-operative levels were 
below 100% as this is not reported as a percentage of pre-operative weight-bearing. 
 Pre-op Day 13 Day 29 Day 34 Day 43 Day 55 
Pig #1 66%  46%  41% 39% 
Pig #2 71% 48%  42%   
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Figure 4.1: Porcine model. a) Pig #2 with a transcutaneous OI prosthesis at 2 days post-op, b) 
Pig #2 at 10 days, c) Pig #2 at 17 days, d) Pig #1 at 47 days. 
 
4.1.2 Assessment of Hypothesis  
It was hypothesized that the pig would be capable of ambulation with a prosthetic leg 
within one week of surgery. The results support this hypothesis as the pigs were walking at day 
six and two, respectively. It was further hypothesized that the pigs would be ambulating at 80% 
pre-operative weight-bearing on the operative limb by the 56 day endpoint. The highest 
percentage weight-bearing observed for pig one was 46% BW at day 29. This corresponds to 
70% of the pre-operative weight-bearing. The highest percentage weight-bearing observed for 
pig two was 48% BW at day 13. This corresponds to 68% of the pre-operative weight-bearing. 
Thus this hypothesis was not supported by the pilot study’s results.  
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4.2 Specific Aim #2: Infection 
4.2.1 Microbiological  
The wound sites for both pigs were sterile immediately following surgery as indicated by 
post-surgical swabs. Swabbing records specified the presence of bacterial types indicative of 
infection for both pigs over the length of the study (Figure 4.2). Psuedomonas aeruginosa and 
Staphylococcus aureus were of particular concern in the porcine model. Positive bacterial 
cultures do not necessarily indicate infection. Instead, cultured pathogens were coupled with 
clinical indications of infection to confirm whether an infection was truly present.  
Pig #1: Yeast was the only species indicated by the bacterial swabs to be growing 
superficially around the transcutaneous implant for the first 44 days of wound healing. 
Superficial Bacillus species and Psuedomonas aeruginosa species were isolated at day 44 and 
49, respectively. Neither of these species colonized successfully as neither were found at the 
following swabbing. At necropsy, a deep tissue bacterial swab indicated the presence of 
Psuedomonas aeruginosa species.  
Pig #2: Yeast and Enterococcus species were indicated by superficial bacterial swabs 
throughout the majority of the study. There was a superficial Staphylococcus aureus species 
isolated at day four. The animal was given 400mg of Simplicef orally for three days. This 
antibiotic regimen effectively eliminated the Staphylococcus aureus species but did not reduce 
the prevalence of the Enterococcus species. Neither superficial Staphylococcus aureus nor 
Pseudomonas aeruginosa were isolated after day six. Unlike in pig #1, switching the cleaning 
solution from hydrogen peroxide to soap and water at day 26 did not cause a resurgence of 
bacteria cultures. The bacterial swabs taken post-mortem near the bone-implant interface were 
non-indicative of deep tissue infection.  
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Figure 4.2: Animal bacterial colonies. a) Pig #1 Bacterial Colonies, b) Pig #2 Bacterial Colonies. 
The Pseudomonas Aeruginosa swabbed in the first animal was confirmed with a deep tissue 
sample. 
4.2.2 Soft Tissue Biopsy 
The deep Psuedomonas aeruginosa species swabbed at necropsy in the first pig was 
confirmed with an aerobic bacterial culture of a deep soft tissue sample. There was no 
presence of deep tissue pathogens indicated by the aerobic bacterial culture in the second pig.  
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4.2.3 Assessment of Hypothesis  
It was hypothesized that neither pig would develop infection by the 56 or 35 day 
endpoints, respectively. A superficial Psuedomonas aeruginosa species was found upon 
swabbing and confirmed at a deep location with a soft tissue biopsy in the first pig.  A 
superficial Enterococcus species was found upon swabbing but unconfirmed with a deep soft 
tissue biopsy in the second animal. There was no clinical suspicion of infection (smell, excessive 
and unusual discharge, inflammation at the surgical site, or temperature spike) in either pig. As 
discussed in SA#1, the animals were receptive to palpation of the wound site and no spike in 
body temperature was noted. As will be discussed in SA#3, there was little inflammation or 
exudate in either animal. The superficial and deep Psuedomonas aeruginosa cultures are 
evidence of a deep tissue infection in the first animal. The superficial Enterococcus culture 
without clinical signs of infection is not evidence of an infection in the second animal. The 
hypothesis for SA#2 was unsupported as one of the two animals developed an infection.  
 
4.3 Specific Aim #3: Wound Healing 
4.3.1 Gross Observation  
The surgical incisions and transcutaneous wounds healed at different rates. The 
incisions healed quicker, undergoing hemostasis and inflammatory phases that were 
characterized by clotting, swelling and warmth. The healing of the surgical incisions progressed 
to the proliferative phase by approximately day three. The tissues surrounding the incisions 
appeared pink as a result of newly formed capillaries. The surgical incisions granulated, 
contracted, and epithelialized at approximately two weeks. Scar tissue was observed at the 
study’s endpoint as the incisions were still in the remodeling phase.  
The transcutaneous wound healing progressed at a much slower rate (Figure 4.3, 4.4). 
Over their first respective weeks, no superficial wound healing could be seen in either pig. A 
pink ring surrounded the metal implants by the end of the second week. This was replaced by a 
purulent whitish/yellowish formation over the third week. Formation of pink granulation tissue 
occurred at approximately three weeks and surrounded the implants for the remainder of the 
study. There was little exudate visualized and little inflammation after the first week. 
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Figure 4.3: Transcutaneous wound healing. a) Post-surgery day two, b) Day 10, c) Day 18, d) Day 
28, e) Day 35, f) Day 53. The transcutaneous wound can be seen progressing through the 
hemostasis phase over the first week which was characterized by the dark tissue surrounding 
the implant. The inflammatory phase was observed at the third week as seen by the yellowish 
exudate in 4.3c. The pink tissue observed after week four is evidence of the proliferative phase 
in which neovascularization develops. The remodeling phase was never reached.  
 
 
Figure 4.4: Transcutaneous wound site at necropsy after implant removal. Note the progression 
of wound healing as traveling from healthy skin to bone.  
d e f 
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4.3.2 Histological Evaluation 
Processed slides were used to assess the extent of epidermal downgrowth, observe the 
inflammatory cells and neovasculature required for wound healing, and determine the cell 
types at the bone-skin-implant interface (Figure 4.5). 
The mature skin was well defined in both pigs as indicated by the appearance of the 
epidermal (stratum corneum, stratum lucidum, stratum granulosum, stratum spinosum, 
stratum basale) and dermal layers when progressing superficial to deep. Epidermal 
downgrowth was evaluated after the termination of the mature skin layer. There was virtually 
no epidermal downgrowth observed in either animal. The developing skin trended away from 
the implant in the first pig but was seen migrating towards the transcutaneous implant in the 
second pig.   
Progressing from deep to superficial at the transcutaneous site, wound healing was 
characterized by a new formation of scar tissue, granulation tissue, fibrin, basophilic material, 
and cell debris. Neovasculature was observed throughout the granulation tissue layer just deep 
to the superficial surface of the transcutaneous wound. Neutrophil granulocytes, which stain a 
neutral pink with H&E, and basophilic white blood cells, which stain a dark blue, can be seen 
populating the transcutaneous site as a response to the inflammatory phase of wound healing. 
There was no histological evidence of a seal at the bone-skin-implant interface in either animal.  
 
 
I 
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Figure 4.5: Histological evaluation of transcutaneous wound. I) 56 day animal, II) 35 day animal, 
4x magnification of transcutaneous section after H&E stain. a) mature epithelial layer, b) 
developing epithelial layer, c) 40x magnification of transcutaneous site; new formation of scar 
tissue, granulation tissue, fibrin, basophilic material, and cell debris. Bone is not pictured in 
either image, but is located further proximally along the implant’s surface. 
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4.3.3 Assessment of Hypothesis  
It was hypothesized that the skin would not adhere to the smooth transcutaneous 
portion of the implant and that there would be a fully developed epidermal layer by the 56 day 
endpoint. Gross observation indicates that there was no skin-to-implant adherence. This 
observation was confirmed at necropsy when the implant was unthreaded from the bone. This 
portion of the initial hypothesis is supported by the results. Histological results indicate that the 
epidermal layer development was ongoing but incomplete. This portion of the initial hypothesis 
is not supported by the results. 
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Chapter 5: Discussion 
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5.1 Specific Aim #1: Pig Model 
Pigs demonstrated incredible agility with an ability to ambulate on three legs for the 
immediate post-operative period. This was crucial for adjustment to the absence of a hind limb 
and balance training. Moreover, the implant without an attached exo-prosthesis limited the 
length of the moment arm during the initial two day recovery. Both pigs were receptive to 
human interaction and were non-reactive if pressure was applied to their amputated leg. 
Human-animal interaction was critical, making it possible to evaluate the operative leg on a 
daily basis. Further, it was observed that the pigs were able to quickly adjust to changes in the 
exo-prosthetic design. Within minutes of attaching a new prosthesis, the animals adjusted their 
gait to compensate for exo-prosthesis design variations. In the human model, the recovery 
steps through a number of prosthetic designs by extending prosthetic length and increasing the 
percentage weight bearing.  The pigs’ suppleness made mimicking this staged recovery 
possible, further depicting the human condition. Overall the pigs seemed to be in very minimal 
pain considering the invasiveness of the surgery and the pace of the recovery. By the second 
week, pig #2 was even voluntarily standing up on its hind legs while leaning on the top of the 
cage with its front legs (Figure 4.1.c). The staged recovery and tissue healing response 
demonstrated a physiological likeness to the human amputee. 
Both pigs started to extend their leg behind them by day 14 and day 23, respectively. It 
is believed that this was due to the suturing of muscle and other soft tissues during surgery. The 
muscle layers may have retracted during the first couple weeks of recovery causing the leg 
extension.  Attempts to retain even more soft tissue will be made in future animal surgeries to 
improve the overall elasticity of the muscle layers. Such a finding could not be documented in 
previous weight-bearing animal models because the level of the amputation was too far distal 
[41, 52, 53].  In those models there was an insufficient amount of soft tissue coverage at the 
transcutaneous site to fully understand the soft tissue response to a transcutaneous OI 
prosthetic. At necropsy, calcification of the tendons in the posterior side of the residual stump 
was also noted. This is a hardening of the tendons thought to occur in areas of reduced blood 
flow where calcium is wrongly developed by local cells. In humans, resulting impingement can 
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be a cause of prosthetic pain. Common sites of socket pain due to tendon calcification are the 
tibial tubercle, frontal tibia, fibular side of the knee, and hamstring tendons [87]. Given the 
seemingly human physiological soft tissue response of both the muscle retraction and tendon 
calcification, it is believed the pig model gives a more accurate portrayal of soft tissue healing 
around weight-bearing, transcutaneous implants than previously reported animal models.  
For pig #2, the threaded, flanged implant held securely throughout the five week study 
and was unscrewed without issue at necropsy. Threading is the same method of bone fixation 
utilized by the OPRA implant. Porous in-growth implant surfaces have also demonstrated 
successful fixation. This is the method of fixation for the ILP and ITAP transcutaneous implants 
as well as typical hip and knee replacement stems. Ease of implant removal will be a critical and 
necessary feature of transcutaneous OI implants developed for human clinical trials in the USA 
in case of infection.   
5.2 Specific Aim #2: Infection 
The hydrogen peroxide solution was effective at keeping the wounds clean as 
demonstrated by the lack of bacterial cultivation for the first 44 days in the first pig. There was 
concern that it may be hindering colonization of normal flora as well, thus inhibiting the wound 
healing process. As such, the wound cleaning solution was switched to a 50% mild detergent 
soap for the remainder of the study. In the first pig, this may have caused an onset of superficial 
Psuedomonas aeruginosa species and Enterococcus species by failing to cleanse the wound of 
debilitating pathogens.  
The day two spike in Staphylococcus species and Enterococcus species for the second pig 
was likely due to contamination. During the first post-operative night, the sling bandage had 
fallen off and been removed by the animal. The open wound was exposed to a contaminated 
pen environment. The wound was cleaned and rewrapped within hours of this happening, but 
non-sterile wood shavings had already infiltrated the wound site. The antibiotic effectively 
eliminated the Staphylococcus species bacterium over the three day regiment, but did not kill 
the Enterococcus species. The wound remained wrapped between cleanings for the remainder 
of the study. Neither superficial Staphylococcus aureus nor Pseudomonas aeruginosa were 
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isolated again, but the Enterococcus species colonized superficially at moderate levels. Unlike in 
the first pig, switching the cleaning solution from hydrogen peroxide to soap and water did not 
cause a resurgence of pathogens. This is a promising result for human users who generally 
prefer a milder cleaning solution. 
The most common bacteria found in the pig model were Enterococcus species, 
Staphylococcus species, and pseudomonas aeruginosa species. This is consistent with human 
studies which have shown the most common bacteria found in the superficial and deep cultures 
around transcutaneous wound sites to be Staphylococcus aureus and coagulase-negative 
staphylococci [27].  
 
5.3 Specific Aim #3: Wound Healing 
Based on gross observation, the wound appeared to be healing over the course of the 
study. Although prolonged by the non-physiologic nature of the transcutaneous implant, the 
wound progressed through the four stages of traditional healing: hemostasis, inflammation, 
proliferation, and remodeling. The hemostasis phase is characterized by vasoconstriction and 
platelet aggregation leading to clot formation. Occurring immediately after surgery, this 
physiological process was evidenced by gross observation of dark tissue surrounding the 
implant. The inflammatory phase is characterized by the release of mediators, recruitment of 
cells, and leukocyte infiltration. Over the first weeks, the yellowish exudate observed at this 
time was perceived to be a byproduct of this response. The proliferative phase results in 
fibroblast propagation and secretion of type III collagen. The increase in structural tissues 
allowed for neovascularization and the formation of granulation tissue. For the remainder of 
the study, this phase was clinically characterized by the pinkish coloration and tissue 
hypertrophy. The later stages of the proliferative phase were never fully realized. In this stage, 
the fibroblasts comprising the granulation tissues further differentiate and secrete type I 
collagen. This process is called epithelialization, resulting in tissue that appears more like 
normal skin. The remodeling phase follows and is characterized by further cellular 
differentiation and organization. This process can take up to two years after injury to complete. 
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A longer study would be required to observe the full spectrum of epithelialization, remodeling 
and maturation of new skin.  
Lacking the clinical observation of new skin maturation, histological techniques were 
used to assess whether a definitive skin seal existed at the skin-bone-implant interface. While 
there was no histological evidence of a definitive skin seal in either animal, there was evidence 
of migration of the epithelial layer towards the transcutaneous site in the second animal. The 
formation of new skin is a time-dependent phenomena, known to occur at approximately one 
millimeter per day in a healthy wound [88]. Assuming the skin continued to trend towards the 
implant, a skin seal may have tried to form. A longer study and more animals would be required 
to see if the migratory pattern observed in the second pig was naturally occurring. This desired 
healing response is imperative as transcutaneous implants intended for permanent fixation to a 
host tissue are entirely dependent on an impermeable junction to the outside environment 
[89].  
Confounding the assessment of the skin seal was the somewhat unsuitable histological 
preparation and cutting protocol. Embedding in paraffin wax required that the transcutaneous 
titanium post be first unthreaded from the bone. Although the implant was removed 
uneventfully, the delicate nature of the tissue-implant interface may have eradicated the 
existence of a skin seal. Previous studies have embedded the specimen and transcutaneous 
metal implant in polymethyl methacrylate (PMMA) [41, 90]. Doing so enables the specimen to 
be sliced with a diamond wire saw and subsequently stained. Such a procedure results in better 
visualization of transcutaneous wound healing and epithelium-implant interaction. A useful 
PMMA embedding protocol has been published but was not used for this study because the 
required equipment was not available [91].  
The porcine model of transcutaneous wound healing also sought to assess the modality 
of skin adhesion.  As discussed in Chapter 1.3.4 and 1.3.6, transcutaneous implant design has 
been altered to encourage a skin seal in both human and animal studies. Bloebaum et al. were 
effective in preventing superficial and deep infection in 14 out of 14 sheep by using a porous 
metal transcutaneous collar [90]. Bachus et al. used a rabbit model to show that porous 
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structures displayed tissue in-growth into the implant while the smooth surfaces induced a 
thick, organized fibrotic capsule unattached to the implant [67]. While these animal studies 
indicate successful outcomes for transcutaneous implants using porous metals, it may be 
biomechanically advantageous to discourage an implant-skin interface. The elastic modulus of 
skin (along fibers), bone and titanium are approximately <1GPa, 18GPa, 115GPa, respectively 
[92, 93]. Compatible material properties help to sustain a two material interface, especially in 
cases of repeated loading such as walking. Inducing skin adherence to a material that has an 
elastic modulus one order of magnitude larger (e.g. bone) as opposed to two (e.g. titanium) 
generates a less strained interface at the attachment site.  
Computational models, animal studies and human clinical trials have studied altered 
implant geometries in an attempt to promote an intact skin barrier. Kuiken et al. used a finite 
element model to verify that a larger surface area for skin adhesion reduces stresses at the 
skin-implant interface. Results indicated a substantial reduction in stress given a broader bone 
base. Bloebaum et al. used the POP implant in a sheep model to demonstrate that skin 
immobilization decreases skin regression around transcutaneous implants [35]. This is the same 
methodology behind the ITAP implant system which consists of a flanged base to immobilize 
the skin.  While expanding the adhesion area seems to reduce skin regression, there is still the 
concern of attaching skin to a non-biologic surface. The ITAP system positions the HA-coated 
flange below the surface epidermal layer. While the flange is perforated to allow biological 
incorporation, short- and long-term vascularization must be maintained to keep the dermal 
tissues from retraction and necrosis. A finite element model of a weight-bearing 
transcutaneous OI prosthesis is being developed at the University of Kansas Medical Center to 
validate the relationship between soft tissue retention and resultant strain (detailed in Chapter 
6, ‘Computational Model Development’).  
An alternative surgical method encourages a seal to form directly to the bone as 
opposed to the implant. Both the OPRA and ILP implant systems directly attach the skin to the 
residual bone [27]. These implant systems utilize a smooth transcutaneous collar to ensure that 
there is no skin-implant incorporation. This smooth transcutaneous surface method has been 
better represented in human clinical trials as approximately 240 out of the 250 European 
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amputees with transcutaneous OI weight-bearing prosthesis have either the OPRA or ILP 
implants. Despite the success of the human clinical trials, there has been very little animal 
research using a smooth transcutaneous portion. Therefore, a smooth transcutaneous portion 
of the implant was chosen for the pig model. By preventing the skin from incorporating with the 
implant, it was theorized that the epidermal layer would grow down and heal at the level of the 
bone.  
As previously discussed, the pig is an appropriate animal model for transcutaneous 
wound healing. Bloebaum et al. acknowledge that human skin may heal in different migratory 
patterns from those seen in the sheep model [90]. Therefore, implant design alterations should 
be investigated in a porcine model which is more physiologically-similar to the human 
condition. Reiterating the need for an appropriate animal model were contradictory 
assessments of a nylon velour transcutaneous coating. Hall et al. concluded an effective skin 
seal for up to 14 months using a goat model while Fernie et al. concluded complete skin 
retraction at 10 weeks using a pig model [51, 54]. While the pig model was weight-bearing and 
the goat model non weight-bearing, the animal models both assessed nylon velour 
transcutaneous materials with completely contradictory outcomes. Before conclusions are 
translated to human studies, they should first be shown effective in a pig model. 
 
5.4 Statistical Limitations  
The author acknowledges that this study only examined the wound healing and 
infection associated with two animals. No statistically significant data was meant to be derived 
from this study. Instead, this was a pilot study intended to assess the use of pigs as a model for 
human transcutaneous wound healing. Techniques for evaluating infection and wound healing 
were reported for suggested use in future studies. 
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5.5 Future Directions  
5.5.1 Future Endo-prosthesis Design 
After completing the two animal pilot study, a modified house of quality was made to 
aid in future implant design iterations (Appendix 11). The rubric scored immediate fixation, 
permanent fixation, in-house manufacturability, axial stability, and torsional stability, and skin 
incorporation as the most important design qualities. The modified house of quality rubric can 
be used in conjunction with the results from the animal study to design future iterations of the 
pig endo-prosthetic. The next iteration of implant design must consider the bone-implant 
interface and the skin-implant interface. 
Anterior/posterior (A/P) and medial/lateral (M/L) radiographs were taken post-mortem 
of the operative leg of both animals (Figure 5.1). The radiographs show evidence of heterotopic 
ossification (HO) on the posterior shaft of the tibia. HO is the presence of bone in areas where 
soft tissue normally exists. Traumatic amputation can be the cause of HO in humans. The 
surgical technique used in this study could have contributed to the HO noted in the pigs.   
     
Figure 5.1: Post-mortem radiographs. a) Pig #1 A/P view, b) Pig #1 M/L view, c) Pig #2 A/P view, 
d) Pig #2 M/L view. Note the HO formation on the posterior shaft of the tibia in both animals. 
Bone cement can be visualized as the white ball proximal to the implant’s tip. The implant 
unthreaded in the first animal as evidenced by the gap between the bone and implant. The 
implant in the second animal did not unthread but was not inserted completely during surgery.  
b a c d 
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In terms of the bone-implant interface, the implant should retain the self-tapping 
cutting flutes. The fluted implant was advantageous for threading the implant in by hand during 
the operation. However, the flute layout could be altered. Screws with more than two flutes 
have been shown to ease insertion and did not cause cortical bone damage [94]. Furthermore, 
three short cutting flutes have been shown to outperform two long cutting flutes in pull out 
strength [95]. Therefore a three 50 percent length cutting flute design should be used in an 
effort to ease insertion while optimizing pull out strength.  
Threading the implant allowed for high levels of initial bone-implant stability in the 
animal model. This result was consistent with other studies which have shown that threaded 
implants improve initial mechanical interlock with bone more than porous-surfaced implants 
[96]. However, after approximately six months, a fibrous connective tissue has been previously 
shown to develop around threaded implants. As a result, the threaded implants lose 
mechanical fixation. A fibrous capsule was not a factor in these animals due to the brevity of 
the pilot study. However, if future porcine studies investigate transcutaneous OI devices over a 
longer time period, porous-surfaced implants are known to stabilize with time through bone 
ingrowth.  
Permanent fixation was not achieved in the first animal as the implant began loosening 
at day 21.  The radiographic images from Figure 5.1 have been cropped and enlarged to show 
the bone-implant interface (Figure 5.2). The threads remained engaged with the bone for the 
56 day animal, especially near the distal end of the bone (Figure 5.2a/b). However, the implant 
loosened due to a lack of torsional stability. The implant remained stable for the second animal 
throughout the 35 day study. However, the A/P radiograph suggests that the bone surrounding 
the distal implant resorbed (Figure 5.2c). This was likely the result of stress shielding as is often 
seen around total hip stems. The denser implant transfers the loads that the bone would 
normally see, effectively shielding the bone from stresses.  According the Wolff’s Law, bone 
material was resorbed by the body due to lack of loading. Over longer periods of time, stress 
shielding can lead to implant loosening. The M/L radiograph suggests less bone resorption 
(Figure 5.2d). The threads appear fully engaged along the implant-bone interface. The gap 
between the distal bone and implant that can be seen on the radiographs was due to the 
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implant not being fully threaded into the bone during the surgery. Future animal surgeries 
should ensure that the threads are inserted all the way into the medullary cavity during surgery 
so it is flush with the distal end of the amputated bone. The soft tissue makes visualization of 
this challenging so this could be better accomplished with intraoperative fluoroscopy if 
available. Due to the high importance of immediate fixation according to the modified house of 
quality, and the thread engagement observed in the post-mortem radiographs, threading 
remains the best choice for achieving mechanical fixation in the pig model. 
    
Figure 5.2: Post-Mortem Radiographs, close-up of the bone-implant interface. a) Pig #1 A/P 
view, b) Pig #1 M/L view, c) Pig #2 A/P view, d) Pig #2 M/L view. Note thread engagement in 
first animal but lack of bone cement and implant incorporation, resulting in lack of torsional 
stability. Potential bone resorption around distal threads for the second animal but improved 
torsional stability due to the bone cement engaging the flat at the proximal implant. 
 
The cylindrical shape of the implant performed suitably as neither bone fractured during 
surgery or post-operatively. The point of greatest stress in the implant-bone construct was 
likely the cortical wall just beyond the tip of the implant. Stress risers likely occurred at this 
point because the load was transferred through the implant up to this point but was then 
distributed through the bone cement to the tibia. A tapered implant would better transfer 
loads through the implant to the bone, but the shape of the pig’s tibia is not suited for a conical 
b a c d 
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implant. The cylinder allowed for a greater bone-implant contact area and will therefore be 
used in future implant iterations.  
The implant design could be altered to better incorporate the bone cement. The bone 
cement appeared to be pushed by the end of the implant and ball up at the proximal diaphysis 
(Figure 5.1a). Due to the position of the cement and the non-incorporative design of the first 
implant, the cement used in the first pig was never useful for torsional stability.  Similarly, the 
bone cement can be seen at the proximal diaphysis in the second animal (Figure 5.1d). 
However, the flat at the proximal end helped incorporate the cement and stabilize the implant. 
The implant could be further improved by changing the flat or cannulating the implant. First, 
the holes might be removed from the flat. The holes remove surface area that would otherwise 
resist implant rotation. Cannulating the implant would allow injection of bone cement after the 
implant had been inserted. Post-implantation injection would allow better incorporation of the 
cement so that the ball is not formed and pushed to the end of the cavity. Further, cannulated 
holes could be included on the sides of the proximal half of the implant so that additional 
fixation could be achieved where the shape of the bone opens up.  
The implants used in the pilot animal study were designed with a smooth 
transcutaneous section that was meant to discourage skin-implant incorporation. It was 
hypothesized that epithelial downgrowth would allow for a biologic seal to be established at 
the skin-bone interface by the study’s endpoint. Results from the porcine model indicated that 
a skin seal was not fully established but that the epithelial layer was migrating towards the 
transcutaneous surface in the second animal. Future design iterations should investigate 
incorporating a porous metal coating at the proximal end of the transcutaneous section of the 
implant. This may allow the skin layer to grow along the implant and provide a scaffold-like 
environment at the skin-bone-implant interface for tissue incorporation.  
5.5.2 Future Exo-prosthesis Design 
After completing the pilot study, a modified house of quality was made to aid in future 
exo-prosthetic design iterations (Appendix 12). The rubric indicated that strength, adjustability, 
in-house manufacturability, and interchangeability of parts were the most important design 
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qualities. The final exo-prosthesis for the second animal remained stable over the course of the 
35 day study (Figure 5.3a). There was wear on the threading of the fiberglass all-thread, thus it 
should be replaced with aluminum all thread in future studies. Although this would slightly 
increase the weight of the prosthetic, the strength has been determined to be more important. 
The angled clamping bracket used for the second animal allowed the leg to be spun and 
clamped at any angle. The angle at which the bracket was clamped affected the positioning of 
the foot for the animal. Overall, the effect on the pig’s gait was minimal and the animal 
continued to load the limb. The final hard foam material choice for the foot was also adequate. 
From observation, the pliability of the material simulated that of the natural foot. Future 
studies could continue to use a similar static prosthetic design if a simple manufacturing 
process is desired. However, to simulate the flexibility and energy storage of a natural ankle, a 
carbon-fibre-reinforced polymer blade could be used (Figure 5.3b). Although the carbon-fibre 
blades have demonstrated great success in human application with conventional prosthetic 
suspension, they have shown mixed results in veterinary applications for use with 
osseointegrated limbs. In one dog, the carbon-fibre blades caused excessive stress on the distal 
bone resulting in fracture [41]. Pig gait would need to be further analyzed before this design 
should be suggested for use with the porcine model.  
 
Figure 5.3: a) Final exo-prosthesis used on the second pig, b) Carbon-fibre blade used on 
transcutaneous osseointegrated canine model. Potential for use of similar blade in porcine 
model but was shown to cause excessive stress to the distal bone resulting in bone fracture in 
the canine model. Image 5.3b reproduced from Fitzpatrick et al. (2010) [41]. 
b a 
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5.5.3 Study Execution 
In regards to study execution, there are a few changes that would enable more 
transparency in the results. First, a more consistent approach should be taken with the wound 
cleaning solution to standardize the care protocol. It is difficult to draw definitive conclusions 
from this study regarding infection because the cleaning protocol was changed during the 
course of the study. Switching the solution from hydrogen peroxide to mild soap water may 
have affected the colonization of debilitating pathogens such as superficial Psuedomonas 
aeruginosa in the first pig. Because this switch was made on both pigs without a control, 
pinpointing the cause of the influx in pathogens is difficult. A future study could compare 
methods of wound care as this is of great importance to the human application. Second, future 
studies should consider use of the PMMA embedding protocol described by Bloebaum et al 
[91]. While embedding in paraffin simplified the cutting process, it was difficult to evaluate the 
bone-skin-implant interface histologically. More convincing histological results of the soft-tissue 
seal are obtainable if the transcutaneous implant is left undisrupted, embedded in PMMA, and 
cut with a diamond wire saw.  Third, future animal studies should consider additional staining 
protocols to strengthen interpretation of histological results. A gram stain would enable 
bacterial species to be identified. This would be advantageous in the assessment of the 
transcutaneous section where bacterium was likely present. A cytokeratin 5/6 or 34 beta stain 
would have highlighted cytokeratin which is a molecular feature of epithelial cells. This may be 
valuable to verify the extent of epidermal downgrowth by staining the epithelial layer. A 
trichrome stain would stain collagen a blue color, fibron a red, and nuclei a dark brown. This 
may be useful for demonstrating the presence of certain cells at the transcutaneous section. 
Finally a CD-31 immunostain was considered to demonstrate endothelial cells that line blood 
vessels. This would be useful for quantifying neovasculature.  
5.5.4 Direction of the Porcine Model 
With respect to the future direction of the pig model, studies should consider different 
methods of decreasing the stress present in the tissues around the transcutaneous portion of 
the implant via material and surface topography changes to improve the skin-implant seal. It is 
well understood that lessening interfacial stress minimizes soft tissue breakdown, thus 
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increasing the likelihood of an intact skin barrier. Results from future animal studies could be 
coupled with computational models to lead in the development of an infection-free 
transcutaneous prosthetic option for humans. 
Further, this pig model has the potential to become an assessment tool of 
transcutaneous OI devices for the diabetic population. Surgeons are hesitant to attempt the 
operation in diabetic amputees because of poor bone quality and vascularization to the 
extremities. This is a patient population which constitutes 864,000 of the 1.6 million amputees 
in the USA and is going to continue to grow. Current trends suggest an increasing number of 
obese Americans [97]. Given the known relationship between obesity and diabetes, the number 
of people with diabetes is expected to nearly double by the year 2030 [98]. That being said, the 
number of amputations secondary to dysvascular conditions is predictable. Due to the aging 
population and increase in number of people living with diabetes, limb loss is expected to more 
than double by 2050, from 1.6 million to 3.6 million. Diabetes mellitus and dysvascular disease 
affect the body’s vasculature, especially in the extremities. Therefore, in order to study 
transcutaneous wound healing for the diabetic population, a translatable animal model is 
necessary. In 2000, Jansen et al. used an alloxan induced diabetic rabbit model to evaluate 
percutaneous devices [99]. Results indicated that there is a delayed tissue response in diabetic 
animals. Diabetes impairs the maturity and neovascularization of connective tissue, leading to 
diminished wound healing and greater rates of infection. In a related study, the group 
evaluated percutaneous OI devices in diabetic rabbits by comparing associated soft and hard 
tissue using clinical, histologic, and histomorphometric techniques [100]. In contrast to their 
previous study, results indicated that diabetes does not have negative effects on the soft tissue 
surrounding the implants. Further, while they observed lower cortical bone density in 
experimental animals, there was no indication of implant-bone loosening. A diabetic pig model 
has been previously developed for wound healing studies with limited success [101]. The model 
induced the diabetic condition using streptozotocin injections in Yorkshire pigs. Future studies 
could use a diabetic pig model to evaluate potential weight-bearing transcutaneous OI 
prosthetic device applications for the diabetic patient population. Findings could be compared 
to the Jansen rabbit model before human diabetic amputees are deemed unsuitable for the 
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prosthetic option. Transcutaneous OI devices have the potential to revolutionize the quality of 
life for these patients if the complications of bone quality and vasculature could be overcome. 
Diabetics are a patient population that are often times wheelchair bound after amputation 
because they have even more skin problems associated with their conventional prosthetic 
suspension. 
Transcutaneous wound healing could also be a potential application for Negative 
Pressure Wound Therapy (NPWT). NPWT has been shown effective in closing wounds, inducing 
growth of granulation tissue, and increasing blood flow to the wound [102-104].  NPWT may 
also prove beneficial by ridding the wound site of inflammatory fluids (enema), pulling the skin 
in tension, stabilizing the surrounding tissues, and creating an environment that is less ideal for 
bacterial expansion. Once the transcutaneous prosthetic option is available, NPWT could be 
coupled to immediately help amputees. The combined techniques would need to be proven 
safe through animal modeling and could be developed in the pig model.  
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Chapter 6: Development of a Computational Model 
 
 
 
 
 
 
 
 
 
 
 
 
72 
 
6.1 Introduction 
To build upon the results of the animal model, a finite element (FE) model is being 
developed at the University of Kansas Medical Center. Few previous computational models 
have attempted to investigate the skin-implant seal, specifically the effects of skin seal 
disruption induced by prosthetic loading. Yerneni et al. hypothesized that a greater fixation 
area between the skin and bone at the distal end of the femur would reduce skin-implant 
stresses [92]. Shear and normal stresses induced by ambulation can create concentrations 
around the transcutaneous OI implant. Results indicated a 90% decrease in interfacial stress by 
increasing the distal cortical bone base thickness from two to eight millimeters.  The study 
concluded that lessening the differential movement at the tissue-implant interface minimizes 
soft tissue breakdown, thus increasing the likelihood of an intact skin barrier. The results 
reiterate clinical findings that interfacial movement is detrimental to the formation of an 
effective tissue-implant seal. Implant design and surgical technique can be altered to reduce 
stresses and subsequent soft tissue breakdown at the transcutaneous site.   
The model being developed at the University of Kansas Medical Center aims to 
investigate the strain in the soft tissue surrounding a transcutaneous OI implant. Strain, as 
opposed to stress, was measured because avulsion was considered as the primary mechanical 
failure modality. Avulsion occurs when surrounding soft tissues tear away from a 
transcutaneous implant due to externally applied mechanical forces. Therefore, a normalized 
measure of deformation in the surrounding soft tissues is more useful for predicting mechanical 
failure between the soft tissue and implant than a measure of force per unit area. We 
hypothesize that retaining a greater amount of soft tissue during surgery to surround the 
implant will result in a reduced distribution of strain at the transcutaneous interface. The 
hypothesis is being investigated with the development of a series of three-dimensional FE 
models of transcutaneous OI implants.  
 
6.2 Methods  
Two models were developed that include an implant, a distal femur, a region of 
subcutaneous soft tissue, and skin. The models were created and analyzed using FEA software 
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(ABAQUS/CAE 6.11-2 Dassault Systèmes, Waltham, MA). Models varied in the amount of soft 
tissue that was left at the distal end of the limb to surround the transcutaneous site. Model A 
represents a case in which minimal soft tissue is retained during surgery while model B 
represents a case in which a greater amount of soft tissue is retained during surgery. The 
amount of soft tissue retained affects how the strain was distributed through the model and 
transmitted to the interface. The geometry of skin-bone attachment also differed between 
model A and model B. In model A, a perpendicular skin-implant interface is established, 
meaning that the skin met the implant at a 90 degree angle (Figure 6.1a). In model B, a 
tangential skin interface is created, meaning that the skin encountered the implant at a 180 
degree angle (Figure 6.1b).  
Normal and shear loads of 50kPa were applied to an approximately 100 cm2 rectangular 
area at the skin surface located on the posterior side of the limb. These loads were chosen to 
simulate the loads imposed on the soft tissue by a 75 kg male rising from a chair and applying 
pressure to the posterior proximal end of the limb. This activity induces stretching of the skin 
on the operative leg. The entire implant was constrained from translation and rotation using 
ABAQUS encastre constraints. The model was meshed using hex elements with a global average 
size of 5.0mm. The hex mesh in the analysis region and surrounding boundary regions was 
refined to an average size of 1.0mm. Material properties were assigned to each of the four part 
geometries (Table 6.1).   
 
Table 6.1: Material properties for computational model. 
Part Behavior Material Property Coefficients 
Titanium Implant [105] Newtonian E = 115 GPa, v = 0.3 
Femur [105] Newtonian E = 18 GPa, v = 0.3 
Muscle [106] Hyperelastic Mooney-Rivlin C10 = 30 kPa, C01 = 10 kPa, K = 60 kPa 
Skin [107] Simplified Neo-Hookean C10 = 1.11 MPa, K = 29.6 MPa 
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6.3 Preliminary Results 
Preliminary results indicate that the amount of soft tissue retained appears to have 
some effect on the strain distribution around the transcutaneous implant. With the skin 
attached to both the implant and bone, Model A produced greater strain in the critical skin-
bone-implant interface compared to model B (Figure 6.1). Strain values of 21% and 9% were 
demonstrated at the same relative location in the analysis region for model A and B, 
respectively. It is well established that micromotion at the transcutaneous site induces tissue 
avulsion and ultimately soft tissue breakdown. Strain levels of 5-20% have been shown to 
promote cellular proliferation, but those over 20% may be detrimental to the skin-bone-implant 
interface [108]. This model suggests that greater tissue retention reduces strain at the skin-
bone-implant interface thus increasing the likelihood of maintaining an intact skin barrier.  
The models assume a full surface tie attachment between the skin layer and the implant 
and bone. This may or may not be clinically achievable and should be further investigated. Such 
investigation could occur with histological analysis in future iterations of the porcine model that 
has been described in the previous thesis chapters. Future finite element studies will 
implement dynamic loading conditions, such as impulses from walking and running gait cycles, 
to better simulate the physiological loadings by amputees. The computational model and 
porcine model are clinically relevant and will be used in conjunction to optimize weight-bearing 
transcutaneous OI prosthetic implant design and associated surgical techniques. 
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Figure 6.1: Strain surrounding the transcutaneous OI implant, a) perpendicular skin-implant 
interface, b) tangential skin-implant interface. The analysis region containing the skin-bone-
implant interface is noted by the dotted white line. Maximum strain values in the analysis 
region were calculated to be 21% and 9% for the models pictured in ‘a’ and ‘b’, respectively. 
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a
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Chapter 7: Conclusions 
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7.1 Conclusions 
This pilot animal study establishes the use of porcine models to evaluate the wound 
healing and infection associated with weight-bearing transcutaneous osseointegrated 
prostheses. The animals used in this study achieved 70% and 67% pre-operative weight-
bearing. The transcutaneous wounds progressed through the hemostasis and inflammatory 
stages of wound healing by the animal’s 35 and 56 day endpoints. The proliferative phase of 
wound healing was not complete and the remodeling stage was never reached. Histological 
evaluation indicated migration of the epithelial layer towards the implant in one animal. 
However, there was no evidence of a definitive seal at the skin-bone-implant interface in either 
animal. Bacterial cultures indicated a likely deep tissue infection in one of the two animals. 
Preliminary results from the computational model suggest that strain can be reduced in the 
critical skin-bone-implant interface by retaining soft tissue during transcutaneous OI surgery.  
Previous large animal models fail to demonstrate physiological similarity but have 
attempted to translate conclusions to the human transcutaneous wound healing condition. The 
porcine model outlined in the previous chapters should replace previous models and become 
the standard for implementing and testing future iterations of weight-bearing transcutaneous 
OI prosthetic devices. Future studies will address the transcutaneous implant’s material, surface 
topography, and biological coatings for eventual translation to human amputees. The animal 
and computational models will continue to be used in conjunction to optimize implant design 
and associated surgical techniques. Efforts to improve the tissue-implant seal and thereby 
prevent bacterial infection must continue. The ability to regulate infection must be 
demonstrated before transcutaneous OI prostheses will be clinically implemented in the USA.   
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Appendices  
Appendix 1: Engineering Drawing for Transcutaneous OI Implant 
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Appendix 2: List of Medication 
Drug Species Class of drug Hazardous 
(yes/no) 
Dose Route Duration of 
treatment 
cephazoline Porcine Antibiotic no 15 - 25 
mg/kg 
IV Preop once 
atropine Porcine Anticholinergic  
Tranquilizer 
Sedative 
no 0.02 – 0.05 
mg/kg 
IM Preop once 
ketamine Porcine Dissociative agent 
(Schedule III) 
no 15 - 25 
mg/kg 
IM Preop and at  
x-ray 
xylazine Porcine Analgesic Sedative no 2.0 mg/kg IM Preop 
(optional) 
isoflurane Porcine Anesthetic no 1 – 2% Inhalation Intraop 
1 to 1.5 
hours 
flunixine 
meglumine 
Porcine Analgesic 
NSAID 
no 1 - 2.2 
mg/kg 
IM (neck) 1 to 5 days 
(every 24 
hours) 
fentanyl Porcine Opioid Analgesic 
(Schedule II) 
no 50 - 100 
µg/hr 
Transdermal 
patch 
Up to 5 days 
(or more if 
needed) 
midazolam Porcine Sedative no 100 - 500 
mcg/kg 
IM or IV Daily: As 
required for 
procedural 
handling 
Beuthanasia-D Porcine Barbiturate mixture 
(Schedule III) 
no 5ml/kg150 
mg/kg (.4 
mL/kg) 
IP Once 
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Lidocaine Porcine local anesthetics no 4.4 mg/kg epidural Once 
(optional) 
Bupivacaine Porcine local anesthetics no 4.4 mg/kg epidural Once 
(optional) 
Morphine 
(preservative 
free) 
Porcine Local Anesthesia No .1 mg/kg 
 
Epidural Once 
(optional) 
Buprenorphine Porcine Opioid Analgesic No .005-.01 
mg/kg 
SQ, IM 1-5 days, 
twice daily 
(Optional) 
Carorifen Porcine NSAID Analgesic No 2-4 mg/kg PO, IM, SQ 1-5 days, 
twice daily 
(optional) 
Omeprazole Porcine Proton pump 
inhibitor – 
treatment for 
gastric ulceration 
No .7 mg/kg PO Once daily, 
as needed 
Famotadine Porcine H2 receptor 
antagonist – 
treatment for 
gastric ulceration 
No .5 mg/kg IM 1-2 times per 
day, as 
needed 
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Appendix 3: List of Surgical Supplies 
From the Orthopedic Research Center  Tools for the Operation - Sterilized LAR  
Sterile Marker 1 Towel clips 3 
Sterile Chucks 8 Needle Driver 2 
4 x 4 Gauze Pads 10 Rat Tooth Forceps 1 
DuraPrep surgical solution 1 Adson Forceps (for skin) 1 
Sterile Drapes 4 Metzenbaum Scissors 1 
Ioban 2 No. 15 Scalpel Handle 2 
Surgical Blades (#15) Box No. 20 Scalpel Handle 2 
Surgical Blades (#20) Box No. 15 Scalpel Blades Box 
3-0 Vicryl Box No. 20 Scalpel Blades Box 
3-0 Ethylon Box Blunt Hohmann Retractor 2 
Silk Ties w/o needle 1 Rasp (file fibula) 1 
Skin Prep Tray 1 Curved Clamps, hemostats 6 
Tegaderm Patch 1 Cobb 1 
Irrigation Syringe 1 Micro-Air Surgical saw 1 
Cautery Pen 1 Bone saw tool 2 
Cautery Ground 1 Micro-Air Hand Drill 1 
Sterile Gloves Box Micro-Air hose 1 
Sterile Gowns 4 K-wire driver 1 
 Non-Sterile Gowns 4 K-wire 1 
Face masks Box Larger Hand Drill (non-sterile) 1 
Foot Covers Box .275” surgical drill bit 1 
Hairnets Box .315” surgical drill bit 1 
Non-sterile latex gloves Box .354” surgical drill bit 1 
Pantepinto Sling 1 .394” surgical drill bit 1 
Coban wrap 1 Bone Cement 1 
Lap Sponges 4 Mixing Cup  1 
Non-Sterile Towels 8 Bone Cement Mixing Tower 1 
Sterile Towels 6 60 mL Syringe for Bone Cement 1 
Hair Clippers 1 Bone Cement Pusher 1 
Mayo Stand Covers 2 SS Skin Punch 1 
Tourniquet 1 Racked opp. scissors 2 
Video Camera 1 Bone clamps 2 
Lab Notebooks 2 Metal Implant 2 
Surgical Calipers 1 Prosthetic Bracket 1 
Light Covers 2 ¼”-20 SS Screws 1 
Saline Bottle ¼” SS Allen Wrench 1 
Suction Hose 1 Implant Tightening Rod (Screw Driver) 1 
 Suction Poole Handle 1 Irrigation Bowls 3 
Micro-Air machine and plug (non-sterile) 1 Ruler 1 
  Drill Guides 4 
  Bone Taker Clamps 1 
  Suction tool handle 1 
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Appendix 4: Surgical Protocol 
SETUP 
1. Prepare skin area approximately 2x size of expected surgical field. 
2. Shave and remove all hair from incision area. 
3. Position the pig on back in dorsal recumbency.   
4. Sterilely prep skin area with Betadine or chlorhexidine scrub followed by alcohol rinse (3 times).  
5. Dry with sterile gauze sponges. 
6. Apply a tourniquet to the thigh.  
APPROACH 
Latero-Anterior Compartment 
7. Mark skin laterally with marker at the anterior tibiotarsal joint.  
8. Mark skin with a fish mouth incision .60” proximal to the joint mark (posterior-medial flap 
includes the heel pad and is longer than the anterior-lateral flap). 
9. Cut skin along incision line.  
10. Clear the fascia and subcutaneous tissue in line with the fish mouth incision.  
11. Tie the large sapheneous vein on lateral anterior side of the tibia with 0 Silk tie. 
12. Cut 3 tendon groups on anterior side as distal as possible (just below the rentinaculum). 
13. Dissect down to the bone at the tibiotarsal joint.  
14. Retract all soft tissue including tendons proximally up the bone.        
Posterior Approach 
15. Create the heel flap by clearing the soft tissue (gastrocnemious and soleus attachments) off the 
calcaneous on the posterior bone (sharp dissection with No.15 scalpel). 
16. Expose the common calcanean tendon. Use cobb to peel all soft tissue off the calcaneal bone, 
Remove only the calcaneous bone leaving a substantial heel pad flap. 
17. Strip the connective tissue bluntly using a cobb from the posterior tibia. 
18. Retract all soft tissues 1.0” proximally to the anticipated bone cut.  
19. Cut through the tibia from an anterior approach (at a pre-specified height) with a bone saw.  
20. Cut the fibula as proximal as possible without destroying soft tissue.  
21. Remove the hock.  
IMPLANT 
22. Initial ream with 7mm diameter bit. Clear cortical bone up 2.1”. 
23. Ream until 9mm diameter bit. Clear cortical bone up 2.1”  
WOUND CLOSURE 
24. Check fit of the implant by tightening into medullary cavity 3 full turns to get threads started. 
25. Suture subcutaneous muscle and soft tissue with 3/0 Ethylon for subcutaneous layers. Close 
from posterior-medial to anterior-lateral, drawing the suture line as far away from the face of 
the distal tibia as possible.  
26. Pull the skin medial to lateral, suture the skin with 3-0 Nylon as far lateral as possible to clear for 
skin punch. 
27. Use k-wire to send through the skin and into the bone’s medullary cavity to line up the skin 
punch. 
28. Use a 3/4” diameter skin punch. Punch through the most distal aspect of the limb in line with 
the implant. Remove the soft tissue leaving a circular hole exposing the implant. 
29. Hand screw in the implant, up through the IM canal, for permanent fixation. (tighten with 
prosthetic attachment).     
30. Do not suture the wound at the soft tissue/ implant interface. Want soft tissue to attach at the 
level of the bone. Wrap the wound, don’t form a seal. 
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Appendix 5: Wound Cleaning Protocol 
Preparing 
1. Uwrap wound.  
2. Unscrew exo-prosthetic bracket.  
3. Remove prosthetic leg.  
4. Remove retention cup.  
5. Swab transcutaneous wound.  
Cleaning 
1. Remove all dried blood and exudates. 
2. Wash with solution. 
3. Dry with gauze.  
4. Apply triple antibiotic ointment using cotton swab.  
Covering 
1. Cut slit in middle of 4x4” gauze pads. Slide over the end of the implant (can use 2x2” after first 
month of wound healing). 
2. Slide retention cup over the implant to hold on the gauze.  
3. Fasten retention cup to the skin using coflex bandaging. 
4. Tighten exo-prosthetic back to the implant using the bracket.  
5. Wrap coflex bandaging over the implant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
90 
 
Appendix 6: Force Plate Analysis 
 
Data Collection: 
1. Orient the platforms and force plate as shown below. 
 
 
 
 
 
 
 
2. Ensure force plate is stable and level.  
3. Walk pig across platform at a steady state. Record the force in the z direction on trials in which 
the operative leg cleanly strikes the force plate.  
 
Data Analysis: 
 
1.      Take the mean of the force in the z direction across trials for each day of data analysis.  
2.      Report as a percentage of animal body weight.  
 
 
 
 
 
 
 
 
 
 
 
 
36” 
y 
x 
z 
144” 
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Appendix 7: Histology Preparation Protocol 
Objectives: This protocol outlines the steps and processes that will be utilized to evaluate specified 
measures of soft tissues for the transcutaneous OI pig study. The primary evaluation is divided into two 
histological procedures: the first is a classic H&E method and the second is a decalcified bone H&E 
method. The primary objectives and related measures are detailed in the following table. 
 
Objective Potential Measures H&E 
Method 
Assess adherence of skin to implant  Area ( % of total possible) 1 
Determine extent of epithelial growth on 
implant 
Length (mm) of proximal skin migration 1 
Evaluate any deep tissue infection Presence of small, gram positive rods 1 
Quantify inflammatory cells Count in predefined area (#/mm2) 1 
Quantify neovasculature  1 
Determine the types of cells at the 
bone/implant/skin interface 
 2 
 
The measures in the above table will be attempted to be determined from histology slides generated by 
the following harvesting and prep procedures. 
Harvesting: The following procedure outlines the process of tissue harvesting from the euthanized 
animal. This process will be repeated for both animals included in this study and will be performed on 
the same day, directly after euthanasia. The harvesting process will yield two tissue specimens, one for 
each of the two H&E methods to be used. 
1. Harvest non-operative hind leg using scalpel, disarticulating at the knee. Immediately store 
specimen in -80˚C freezer.  
2. Harvest amputated (operative) leg using a scalpel. Disarticulate the leg at the knee, ensuring 
that the soft tissue surrounding the implant and tibia are intact. 
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3. Make an anterior longitudinal incision along the length of the specimen. Take incision all the 
way down the bone proximal of the implant-bone interface (distal most portion of tibia). 
 
 
4. Being careful not to disrupt any soft tissue at implant-tibia interface, carefully unthread and 
remove implant from tibia. Hold proximal most portion of tibia in a clamp to help stabilize 
during implant removal.  
5. Mark a vertical line over the end of the leg, splitting the leg in half.  
 
 
 
 
 
6. On the medial side, using a scalpel, carefully resect tissue off the implant and bone moving 
circumferentially, from anterior to posterior, trying to maintain a consistent, unbroken piece of 
removed tissue. Orient the epithelial layer face up.  
 
 
 
 
7. Lay the resected distal tissue from step 4 with the epithelial (inner most) layer facing up. Using a 
horizontal incision, resect the top 6mm of the specimen in a single sheet (removing the 
epithelial layer with a thin layer of muscle/extra tissue on its back side). Freeze remaining extra 
tissue for possible future use/analysis (-80C freezer). 
 
 
 
8. Pin resected sheet facing up (epithelial layer up) on a paraffin block as flat as possible.  
Keep Epithelial layer 
External skin surface 
~6m
m 
 
~15mm 
 
~25mm 
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9. Fix the pinned sheet in formalin for 48hrs. This specimen will be used for the first H&E method. 
10. On the lateral side of the specimen (see step 5), remove all soft tissue from tibia starting that is 
not 20mm from the distal end of the bone. Try to minimize any disruption of soft tissue on the 
distal end of the tibia. 
 
 
 
11. Using a fine-toothed hacksaw, transversely cut the tibia ~10mm from the distal end.  
12. Pin the distal-most portion of bone and soft tissue specimen to a paraffin block. Soak in formalin 
for 48hrs. This ~10mm thick specimen with the remaining soft tissue will be used for the second 
H&E method.  
13. Freeze all bone/soft tissue not used in steps 9 or 12 for possible future use/analysis (-80C 
freezer). 
 
 
 
 
 
 
 
 
 
Potential 
Epithelial Seal 
Bone 
Implant 
Soft Tissue 
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Appendix 8: Histology Processing and Embedding Protocol 
Solution Time Temperature Notes 
Neutral Buffered 10% Formalin 48 hours Room  
70% Alcohol Solution 24 hours Room Not necessary 
RBD Decalcifying Solution 1 hour Room Using stir plate. Skip this step if 
specimen does not contain bone. 
Running Tap Water Rinse 10 minutes Room  
70% Alcohol 3 hours Room Vacuum and Pressure 
95% Alcohol 3 hours Room Vacuum and Pressure 
100% Alcohol 3 hours Room Vacuum and Pressure 
Xylene 3 hours Room Vacuum and Pressure 
Paraffin Liquid 4.5 hours Room Vacuum and Pressure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
95 
 
Appendix 9: Histology Cutting and Staining Protocol 
Step Time 
Cut to 4-5 micron thickness  
Air dry 12 hours 
Bake at 65˚C 30 minutes 
Deparaffinize  
Hematoxylin and Eosin Phloxine Stain  Routine Manner 
Permanently Mount  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
96 
 
Appendix 10: Gait Progress and Monitoring  
0 = not used at all 
 1 = supported incidentally 
 2 = loaded in a standing position and incidentally while walking 
 3 = loaded in a standing position and while walking but with a limp 
 4 = normal walking and standing pattern 
 
Animal #: 4172  
Date of Surgery:  11/12/12 
31 0     1     2     3     4  
32 0     1     2     3     4  
Days post op Gait Notes 
1      0     1     2     3     4 Occasionally gets up 
2 0     1     2     3     4 Will get up  
3 0     1     2     3     4  
4 0     1     2     3     4  
5 0     1     2     3     4  
6 0     1     2     3     4  
7 0     1     2     3     4  
8 0     1     2     3     4  
9 0     1     2     3     4  
10 0     1     2     3     4  
11 0     1     2     3     4  
12 0     1     2     3     4  
13 0     1     2     3     4  
14 0     1     2     3     4  
15 0     1     2     3    4  
16 0     1     2     3     4 Stretching leg 
17 0     1     2     3     4  
18 0     1     2     3     4  
19 0     1     2     3     4  
20 0     1     2     3     4 Exo-Prosthesis Change 
21 0     1     2     3     4  
22 0     1     2     3     4 Exo-Prosthesis Change 
23 0     1     2     3     4  
24 0     1     2     3     4 Exo-Prosthesis Change 
25 0     1     2     3     4  
26 0     1     2     3     4  
27 0     1     2     3     4  
28 0     1     2     3     4  
29 0     1     2     3     4  
30 0     1     2     3     4  
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33 0     1     2     3     4  
34 0     1     2     3     4  
35 0     1     2     3     4  
36 0     1     2     3     4  
37 0     1     2     3     4  
38 0     1     2     3     4  
39 0     1     2     3     4  
40 0     1     2     3     4  
41 0     1     2     3     4  
42       0     1     2     3     4  
43       0     1     2     3     4  
44 0     1     2     3     4  
45 0     1     2     3     4  
46 0     1     2     3     4  
47 0     1     2     3     4  
48 0     1     2     3     4  
49 0     1     2     3     4  
50 0     1     2     3     4  
51 0     1     2     3     4  
52 0     1     2     3     4  
53 0     1     2     3     4  
54 0     1     2     3     4  
55 0     1     2     3     4  
56 0     1     2     3     4  
 
Animal Number: 4178 
Date of Surgery:  12/3/12 
Days post op Gait Notes 
1      0     1     2     3     4 Loads Incidently 
2 0     1     2     3     4 Three leg walking 
3 0     1     2     3     4 Exo-Prosthesis attached 
4 0     1     2     3     4 Weight Bearing 
5 0     1     2     3     4  
6 0     1     2     3     4  
7 0     1     2     3     4  
8 0     1     2     3     4  
9 0     1     2     3     4 Slight limp 
10 0     1     2     3     4  
11 0     1     2     3     4  
12 0     1     2     3     4  
13 0     1     2     3     4  
14 0     1     2     3     4  
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15 0     1     2     3    4 Got up on back legs 
16 0     1     2     3     4  
17 0     1     2     3     4  
18 0     1     2     3     4  
19 0     1     2     3     4  
20 0     1     2     3     4 Healthy gait 
21 0     1     2     3     4  
22 0     1     2     3     4  
23 0     1     2     3     4 Extending leg, stretch 
24 0     1     2     3     4  
25 0     1     2     3     4  
26 0     1     2     3     4  
27 0     1     2     3     4  
28 0     1     2     3     4  
29 0     1     2     3     4  
30 0     1     2     3     4  
31 0     1     2     3     4  
32 0     1     2     3     4  
33 0     1     2     3     4  
34 0     1     2     3     4 Some hobbling 
35 0     1     2     3     4  
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Appendix 11: Modified house of quality for endo-prosthesis and implant-bone 
interface 
Legend: ▲= 1 point, Ο = 2 points, Θ = 3 points 
Direction of Improvement  ▼ ▼ ▼ ▲ ▼ ▼ ▼   
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Immediate fixation upon 
implantation 
10 Θ Θ ▲ ▲   Θ 11 110 
Permanent fixation 
throughout the study 
10 Ο Ο  Θ   Θ 10 100 
Surface cleanable with 
hydrogen peroxide and 
soap/water solution 
6 
 
 
    ▲  1 6 
Autoclavable 8      ▲  1 8 
Biocompatible 8 Ο       2 16 
Facilitates skin incorporation 
to bone or implant 
10 Ο Ο      4 40 
Manual insertion technique 7    Ο   Ο 2 28 
Removable if infection 
confirmed 
6   Ο   Θ Θ 8 32 
Withstand axial forces up to 
356N (2.0 FoS) 
9    Θ   Θ 6 54 
Withstand torques up to 60 
N-m (2.0 FoS) 
9    Θ   Θ 6 54 
Scalable to fit any porcine 
medullary cavity 
7      ▲  1 7 
Manufacturable in the 
Orthopedic Research Lab’s 
machine shop 
9 Θ Θ   ▲ Ο  9 81 
Target Value  100 10 2 300k 200 1 6   
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Qualities 
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Appendix 12: Modified house of quality for exo-prosthesis (including the brackets, 
prosthetic leg, prosthetic foot, and all hardware). 
Legend: ▲= 1 point, Ο = 2 points, Θ = 3 points 
Direction of Improvement  ▼ ▼ ▲ ▼ ▼ ▼   
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Adjustable angle 7  Θ Θ  ▲ Ο 9 63 
Adjustable length 7  Θ Θ  ▲ Ο 9 63 
Attach endo-prosthesis in less than 
30 seconds 
5 
 
 
   Θ Ο 5 25 
Detach endo-prosthesis in less than 
15 seconds 
5     Θ Ο 5 25 
Able to be withstand dirt, moisture, 
excrement, urine 
7    ▲   1 7 
All components rated to axial 356N 
(2.0 FoS) 
9 Ο  Θ Ο  Ο 9 81 
All components rated to torsional 
60N-m (2.0 FoS) 
9 Ο  Θ Ο  Ο 9 81 
Brackets under 38mm in height 6   ▲ Ο   3 18 
Replaceable parts including 
prosthetic feet 
6 Ο Ο   Ο ▲ 7 42 
Simulate natural point of contact 
for foot 
7   Ο    2 14 
Simulate natural contact material 
and surface  
7   Ο ▲   3 21 
Manufacturable in the Orthopedic 
Research Lab’s machine shop 
9 Ο Θ    Ο 7 63 
Target Value  50 8 356 1500 30 15   
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